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 The reticular thalamic nucleus (RTN) is a thin band of neurons that lies between the 
cortex and the rest of the thalamus. Most of the inputs to the nucleus are from collateral axons 
of thalamocortical and corticothalamic projections. The basal ganglia, basal forebrain and 
brainstem also have important connections to the RTN. The RTN has previously been 
characterized as an exclusively GABAergic nucleus that causes inhibition of thalamic relay 
neurons and modulates motor messages through thalamocortical projections. However, a 
small number of studies suggest that the RTN is not exclusively GABAergic, but did not 
define the phenotype of non-GABAergic neurons. The RTN is divided into sectors that 
represent all sensory modalities, and the limbic and motor systems. Each sector is closely 
connected to the functionally related thalamic regions. For example, the motor sector of the 
rostral RTN (rRTN) projects to the motor thalamus and receives inputs back from the motor 
thalamus, as well as from the motor cortex and the basal ganglia. This motor sector is active 
during movements and its activity changes with movements to coordinate the motor signals 
that are passed to the motor cortex. Despite its involvement in movement, the rRTN is not 
usually considered in movement related disorders such as Parkinson’s disease (PD). PD is a 
neurodegenerative disorder that is characterized by substantial loss of dopamine neurons in 
the substantia nigra pars compacta and the ventral tegmental area. Loss of these midbrain 
dopaminergic neurons underlies the hallmark motor symptoms in PD patients such as 
bradykinesia, akinesia, resting tremor and rigidity. 
  To advance the understanding of the RTN and its role in PD, this study aimed to 
characterize the phenotype of neurons within the rRTN of adult rats and investigate the effect 
of 6-hydroxydopamine (6-OHDA) induced lesions of midbrain dopaminergic neurons on the 
number and morphology of neurons in the rRTN. Chromogenic and fluorescent 
immunohistochemistry for the GABAergic marker GAD67 and the glutamatergic marker 
CaMKIIα confirmed that the majority of neurons were indeed GABAergic and a small novel 
population of neurons exist in the rRTN that are CaMKIIα positive. Furthermore, a lentiviral 
vector was injected into the rRTN that selectively labelled neurons expressing CaMKIIα with 
the fluorophore mCherry. Detection of mCherry in transduced neurons and GAD67 with 
fluorescent immunohistochemistry confirmed that there are two distinct populations of 
neurons in the rRTN. Chronic dopamine lesions were induced in the left hemisphere of the 
brain by the injection of the neurotoxin 6-OHDA. Stereological investigations into the 
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number and morphology of neurons in the rRTN revealed that 6-OHDA lesion induced a 20% 
increase in the number of GABAergic neurons and also produced a 20% decrease in the size 
of GABAergic neurons in the rRTN. These changes were not seen in glutamatergic neurons. 
 These data indicate that the rRTN is not exclusively GABAergic, as once thought, and 
although small, this glutamatergic population may play an important role in RTN function. 
Furthermore, dopamine depletion causes a number of changes in the rRTN, therefore, the 
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1.1 The reticular thalamic nucleus 
1.1.1 Overview 
 The reticular thalamic nucleus (RTN) is associated with regulating the flow of 
information from the thalamus to the cortex, and is involved in a number of processes such as 
movement, attention, and sleep (Pinault, 2004). The RTN is not often implicated in the 
pathophysiology of the movement-related Parkinson’s disease (PD), however, patients will 
experience problems with sleep and attention as well as the hallmark motor deficits associated 
to the disease (Jankovic, 2008). Furthermore the RTN has a functional relationship with the 
motor thalamus and the motor-related basal ganglia (Pinault, 2004; Lam and Sherman, 2015) 
and therefore the RTN becomes an interesting target in the study of the pathophysiology of 
PD. The literature below, about the RTN, will summarize its connections with nuclei 
throughout the brain, its basic anatomical and physiological features as well as its specific 
connections with motor related nuclei of the basal ganglia and the motor thalamus that are 
implicated in the pathophysiology of PD. This thesis will explore the phenotype of neurons in 
the rostral portion of the RTN and examine the changes that may occur to the number and 
morphology of these neurons in an animal model of PD. 
 The RTN is a thin sheet of neurons that lies between the thalamus and the cortex 
(Houser et al., 1980). The RTN surrounds the lateral portion of the anterior thalamus, 
covering both dorsal and ventral surfaces (Jones, 1975). It is located medial to the internal 
capsule and ventral to the zona incerta (Pinault, 2004). Almost all functional modalities are 
encoded by the RTN, which receives most of its inputs from the rest of the thalamus and the 
cortex. Information, from visual, auditory, somatosensory, gustatory, visceral sensations, 
limbic or motor systems, are topographically represented in the RTN in so called ‘sectors’ 
(Pinault, 2004). It is thought that these cortical and thalamic inputs to the RTN are collaterals 
from the corticothalamic and thalamocortical projections, respectively (Guillery and Harting, 
2003), and give the RTN its characteristic reticulated shape (Figure 1.1). The RTN also 
receives input from areas of the brainstem, the basal forebrain and some of the basal ganglia 
nuclei (Ferrarelli and Tononi, 2011), which will be discussed in more detail below.  
 Francis Crick (1984) originally proposed the ‘searchlight’ hypothesis where the RTN 
searches through the thalamic inputs before they go to the cortex and ‘lights’ up the inputs 
that need to be attended to by inhibiting the inputs of lesser importance (Crick, 1984). 
Consistent with this idea, it is now thought that the RTN plays an important role in attention, 
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as well as the generation of sleep spindles – a characteristic pattern of oscillatory activity that 
is visible on an electroencephalogram (EEG) during sleep (Ferrarelli and Tononi, 2011). 
Currently, the RTN is primarily characterized as a nucleus that contains neurons that make the 
neurotransmitter γ-aminobutyric acid (GABA) thus is defined as a GABAergic nucleus 
(Houser et al., 1980), which accounts for its primary inhibitory function. It is important to 
stress, however, that early studies into the RTN stated that although the RTN is mostly made 
up of GABAergic neurons, it may not be the only neurotransmitter present (Houser et al., 
1980). Despite this, many studies have been based on the premise that the RTN is exclusively 
GABAergic and the possibility of another phenotype of RTN neurons has been overlooked. 
1.1.2 Anatomical description of the reticular thalamic nucleus 
 Early evidence suggested that the RTN contained at least 3 morphologically distinct 
populations of neurons that included both small (1) and large (2) fusiform shaped neurons 
with an elongated perikarya and (3) neurons with a round perikaryon that are multipolar 
(Spreafico et al., 1991). However, later studies found no evidence to distinguish between the 
small and large fusiform neurons (Lübke, 1993). The morphology of the neurons in the RTN 
remains controversial, as many descriptions are available, however, it seems that the 
description of RTN neuron morphology depends on the plane of sectioning used in a 
particular study (Pinault, 2004). It is likely that there are three types of RTN neurons: 1) large 
fusiform neurons that have 2 to 4 primary dendrites emerging from both poles of the 
 
Figure 1.1. An example coronal image of glutamic acid decarboxylase (GAD) staining 
for GABAergic neurons in the RTN. This staining reveals the classical reticulated structure 
of the nucleus that is surrounding the lateral portion of the thalamus (Adapted from Houser et 
al., 1980). RT = reticular thalamic nucleus, ic = internal capsule, T = thalamus, P = putamen. 
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perikarya that branch into secondary dendrites a short distance from the cell body and tertiary 
terminal dendrites at a long distance from the cell soma; 2) medium size fusiform neurons 
with ellipsoid cell bodies, found mainly in the medial part of the RTN with primary dendrites 
projecting from the somata that give rise to secondary and tertiary dendrites (Spreafico et al., 
1991; Nagaeva and Akhmadeev, 2006) and 3) small multipolar cells with round perikarya, 
which have up to 8 smooth primary dendrites that branch into two to three spiny secondary 
dendrites and sometimes into tertiary dendrites (Spreafico et al., 1991). This third morphology 
has mainly been found in the rostral portion of the nucleus (Spreafico et al., 1991).  
 Houser et al. (1980) identified that GABA was the primary neurotransmitter in the 
RTN and stated that the majority of neurons in the nucleus were likely GABAergic. 
Following this, many studies label the RTN as an exclusively GABAergic nucleus, however, 
there is some evidence to the contrary and another minor population of neurons may exist in 
the RTN. As mentioned above, 3 types of neurons are found to be in the RTN, 2 of which 
match the morphological profile of GABAergic neurons, but the small round neurons are 
different (Spreafico et al., 1991). This third morphology of neurons has been found to 
represent a small population in the RTN and is negative for staining against GABAergic 
markers (Nagaeva et al., 2006; Çavdar et al., 2013), but to date, they have not been 
characterised. 
 Ohara and Liberman (1985) observed that in adult rats the size of neurons in the RTN 
changes through its rostro-caudal axis. Neurons in the caudal portion of the RTN had an area 
of 115 - 125 µm2 whereas rostral neurons had an area of 150 - 200 µm2 (Ohara and 
Lieberman, 1985). The morphological profile of each neuron was not determined, therefore, 
these measurements would include small and large morphologies, which may account for the 
range seen in the rostral portion (Ohara and Lieberman, 1985). Primary, secondary and 
tertiary dendrites are found on neurons throughout the RTN (Spreafico et al., 1991; Lübke, 
1993). Primary dendrites are the longest, and often give rise to secondary dendrites that can 
then branch into tertiary dendrites. Generally, primary dendrites are smooth, and it is the 
secondary or tertiary dendrites that have dendritic spines, varicosities and hair-like projections 
suggesting that this is where incoming information is targeted (Lübke, 1993). Synaptic 
terminals in the RTN from its afferent inputs are described as small, large or GABA 
containing (Nagaeva et al., 2006). Large and small-type terminals are from thalamocortical 
and corticothalamic collateral axons and will be discussed with more detail blow. 
GABA-containing terminals, presumably either from afferents to the RTN from the basal 
ganglia, basal forebrain and brainstem or interconnections between RTN neurons, which are 
discussed below, formed around 10% of synapses in the RTN (Liu and Jones, 1999; Pinault, 
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2004), however this description may need updating due to the diverse nature of inputs from 
these locations (see below).  
 RTN neurons express a variety of receptors to accommodate the heterogeneity of their 
inputs (Nagaeva et al., 2006). In this section the phenotype of these receptors will be 
described, the origin of the inputs to these receptors will be explained below and their actions 
on the RTN will be outlined in Section 1.1.3. Glutamatergic inputs to the RTN act via the fast 
acting ionotropic receptors: α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA), and N-methyl-D-aspartate (NMDA) receptors, as well as the slower G-protein 
coupled, group I and group II, metabotropic glutamate receptors (mGluRs) (Cox and 
Sherman, 1999). GABAergic inputs to the RTN activate both ionotropic GABAA and 
metabotropic GABAB receptors, however, the main action is through the GABAA receptor 
(Sun et al., 2012; Seo and Leitch, 2014, 2015). The substantia nigra pars compacta (SNc) has 
a dopaminergic projection to RTN neurons where dopamine D4 and D1 receptors are 
expressed in the RTN (Huang et al., 1992; Mrzljak et al., 1996; Florán et al., 2004). D4 
receptor expression was later localized to the presynaptic terminals of afferent inputs from the 
basal ganglia (Gasca-Martinez et al., 2010; Erlij et al., 2012), however, D1 receptors have not 
been characterized further. RTN neurons also express the nicotinic (nAChRs) and muscarinic 
cholinergic receptors (mAChRs) (Beierlein, 2014), as well as receptors to noradrenaline α1-
receptors (McCormick and Wang, 1991). Serotonergic innervation from the brainstem acts 
via the G-protein coupled 5-HT1A and 5-HT2A receptors that are present on the soma and 
dendrites of RTN neurons (Rodríguez et al., 2011). 
 RTN neurons are thought to have a widely dispersed interneuron population, which 
has recently become controversial (Hou et al., 2016). Early evidence suggested that some 
neurons of the RTN had short axons that did not extend out of the nucleus and provided a 
pathway for communication between RTN sectors (Crick, 1984; Sun et al., 2012). These 
interneurons allegedly provide GABAergic inhibition to the interconnected network of 
neurons (Lam et al., 2006), however, there is limited evidence of this. Sun et al. (2012) 
stimulated slices of the RTN either electrically or with GABAA agonists and found that 
synaptic GABAA receptor activation led to burst responses in RTN neurons. In this kind of 
preparation electrical stimulation of the RTN could be activating any of the fibres that pass 
through RTN that give it the characteristic reticular appearance. Furthermore, GABAB type 
receptors, which act in unison to shape the response to GABAergic stimulation in the RTN 
(Lam et al., 2006), were blocked with antagonists during the experiments performed by Sun et 
al. (2012) and could account for the responses seen by this group. Selective activation of 
GABAergic neurons in the RTN with optogenetics produced inhibitory response of RTN 
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neurons in mice under 2 weeks of age, but failed to elicit inhibitory responses in RTN neurons 
of older mice (Hou et al., 2016). Therefore, it seems that the interneuron population of 
neurons in the RTN is extremely complex and is strongly expressed at an early age. Although 
RTN interneurons may not exist in adults, they may communicate via electrical synapses with 
immediate neighbours (Blethyn et al., 2008). This local inhibition of RTN neurons may 
facilitate the processing of information that requires the most attention by inhibiting or 
silencing surrounding inputs that are less important (Blethyn et al., 2008; Ferrarelli and 
Tononi, 2011), tying RTN function back to the original ‘searchlight’ hypothesis proposed by 
Crick (1984). 
 Thalamic nuclei can be classified as either first-order or higher-order nuclei defined by 
the primary ‘driver’ input, that is the input that drives activity in the thalamic relay neurons 
(Sherman and Guillery, 1998). First order nuclei receive driver input from ascending sensory 
information (i.e. retinal ganglion input into the lateral geniculate nucleus) and then relay this 
information to the cortex (lateral geniculate nucleus to the visual cortex). Higher order 
thalamic nuclei receive driver input from layer V of the cortex and relay this information to 
other areas of the cortex. This is important to keep in mind, as the RTN sends axons to both 
first and higher order nuclei. However the RTN is not classified as a ‘driver’ nor does it 
receive any driver input. It is classified as a ‘modulator’, where it influences information 
processing by thalamic relay cells, but it does not directly trigger activity (Sherman and 
Guillery, 1998). 
 Afferent connections to the RTN The principal inputs to the RTN are from layer VI 
projections of the cortex and thalamic relay nuclei. However the brainstem, the basal 
forebrain, and the basal ganglia also have inputs to the RTN (Figure 1.2) (Guillery et al., 
1998; Ferrarelli and Tononi, 2011). 
 The inputs from the thalamus and cortex are axon collaterals of excitatory 
glutamatergic thalamocortical and corticothalamic projections, respectively (Cornwall et al., 
1990; Liu and Jones, 1999). Thalamic relay cell projections to the RTN typically terminate 
with asymmetric synaptic contact principally onto primary dendrites but also made contacts 
onto the distal second and third order dendrites as well as the somata (Liu and Jones, 1999; 
Deleuze and Huguenard, 2016). Thalamic relay axon terminals are derived from collateral 
axons of thalamic projection fibres as they make their way to the cortex and are large 
excitatory terminals that make up 30-40% of synapses found in the RTN (Liu and Jones, 
1999). Cortical projections come from collaterals of neurons from layer VI that are on their 
way to the thalamic relay neurons. Cortical terminals are small excitatory terminals which, 
make asymmetric contact with neurons, mostly on secondary or tertiary dendrites and these 
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terminals form the majority of synapses in the rRTN (Liu and Jones, 1999). Synaptic contacts 
with proximal first-order dendrites and somata have also been observed, however these are 
less frequent than synapses with distal dendrites (Liu and Jones, 1999).  
 The basal forebrain and brainstem both have cholinergic projections to the RTN. The 
nucleus basalis of the basal forebrain and the pedunculopontine and laterodorsal tegmental 
nuclei in the brainstem send cholinergic projections to the RTN that contain numerous 
synaptic varicosities some of which, terminate with asymmetric synapses on secondary and 
tertiary dendrites of RTN neurons, however, many do not appear to be associated with RTN 
dendrites (Hallanger et al., 1987; Hallanger and Wainer, 1988). It has been suggested that 
cholinergic afferents to the RTN communicate via extrasynaptic and presynaptic receptors as 
well as conventional postsynaptic transmission indicating a possible role of the cholinergic 
system in the plasticity of RTN neuron responses (Beierlein, 2014).  
 Noradrenergic projections from the locus coerulus of the brainstem terminate with 
excitatory asymmetric synapses onto the primary, secondary and tertiary dendrites of RTN 
neurons (Asanuma, 1992). These projections have also been seen to make synaptic contact 
 
Figure 1.2. A schematic diagram of the afferent and efferent connections of the RTN. 
Corticothalamic projections are represented by the light blue neuron and synapse onto 
secondary and tertiary dendrites of the RTN neurons. The dark blue neuron represents the 
thalamocortical projections that contact the somata and the dendrites of RTN neurons. The 
RTN projection to the thalamus is represented by the red neuron and is synapsing onto the 









with the somata of RTN neurons, and seem to come off axon collaterals that primarily project 
to the dorsal thalamus (Asanuma, 1992). However, noradrenergic projections have received 
little attention in studies of the RTN. Similarly, the serotonergic projections from the raphe 
nucleus of the brainstem have not been extensively studied. However, these serotonergic 
projections innervate the RTN with a moderate density and contain small varicosities that are 
regularly spaced (Rodríguez et al., 2011). The ventral tegmental area (VTA) has projections 
to the RTN (Kolmac and Mitrofanis, 1998), however the phenotype or action of these 
projections are yet to be defined. 
 From the basal ganglia, the external segment of the globus pallidus (GPe) and the 
substantia nigra pars reticulata (SNr) send GABAergic projections to the RTN (Paré et al., 
1990; Kayahara et al., 1994; Kayahara and Nakano, 1998) and the SNc sends dopaminergic 
projections to the RTN (Anaya-Martinez et al., 2006). Pallidal projections arborize profusely 
around RTN dendrites, and synaptic varicosities make symmetric contacts with primary 
dendrites and the somata of RTN neurons (Hazrati and Parent, 1991; Paré and Steriade, 1993; 
Asanuma, 1994; Kayahara and Nakano, 1998). Similarly, SNr projections make symmetric 
contact onto the primary dendrites and somata of RTN neurons (Asanuma, 1994). GPe and 
SNr projections are mostly to the rostral portion of the RTN (Pare et al., 1990; Asanuma et 
al., 1994). Projections from the SNc are yet to be fully characterized. Due to the intimate 
involvement of the basal ganglia in the initiation and execution of movement, these inputs 
along with inputs from the motor thalamus and motor cortex will be considered in more detail 
in Section 1.1.7.  
 Efferent connections of the RTN Following Golgi impregnation, Scheibel and 
Scheibel (1966) confirmed that RTN axons project to thalamic nuclei. The RTN projects to 
most of the anterior, dorsal, intralaminar, posterior and ventral thalamic nuclei, however, no 
other targets outside thalamic nuclei have been discovered to date (Scheibel and Scheibel, 
1966; Jones, 1975; Pinault, 2004). The axons of RTN neurons can emerge from the somata or 
primary dendrite and often project into the rest of the thalamus perpendicular to the 
thalamic-RTN boundary (Pinault and Deschênes, 1998).  
 RTN axonal projections to thalamic nuclei are organized in different ways that depend 
on the degree of overlap of the dendritic arbour of individual RTN neurons (see Figure 1.3 for 
a summary) (Pinault, 2004). Adjacent RTN neurons without an overlapping dendritic tree will 
project axons into two distinct sections of corresponding thalamic nuclei (Figure 1.3 A), 
however, adjacent RTN neurons with overlapping dendritic arbours will have overlapping 
axon terminals in corresponding thalamic nuclei (Figure 1.3 B) (Pinault et al., 1997). A small 
percentage of RTN neurons have an axon that splits into 2 branches that terminate in 
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functionally related first-order and higher-order thalamic nuclei (Figure 1.3 C) (Crabtree, 
1998; Pinault and Deschênes, 1998). Similarly a RTN neuron that has an overlapping 
dendritic tree with an adjacent neuron will each project one axon to a corresponding nucleus 
and have overlapping axon terminals, as above, plus another axon to a separate thalamic 
nuclei that is involved in a related function (Figure 1.3 D) (Pinault and Deschênes, 1998).    
 RTN projections terminate in an F type terminal with pleomorphic flattened synaptic 
vesicles and symmetrical synaptic contacts with postsynaptic neurons, indicative of an 
inhibitory functional connection (Ohara et al., 1980; Montero, 1983). These F terminals from 
the RTN have been immunohistochemically identified at light and electron microscope levels 
as GABA-positive terminals and electrophysiology confirms that RTN synapses have an 
 
Figure 1.3. Schematic diagrams summarizing the organization of RTN axonal 
projections to the motor thalamus. (A) Two adjacent RTN neurons innervate two adjacent 
regions within motor thalamus (VA/VL). (B) Two adjacent RTN neurons with overlapping 
dendritic arbours project innervate VA/VL with overlapping axonal terminal fields. (C) A 
RTN neuron can have two distinct axonal fields within first-order and higher-order divisions 
of VA/VL (see Section 1.1.5). (D) A RTN neuron with an overlapping dendritic tree will have 
an overlapping axon terminal field in VA/VL, can also have another axon terminal field in the 
functionally related thalamic nucleus, such as the intralaminar thalamic Pf-CM complex 
(Pinault and Deschênes, 1998). Figure adapted from Pinault and Deschênes, 1998. 
RTN = Reticular thalamic nucleus, Pf-CM = Parafascicular-centromedian thalamic nuclei, 















Motor sector Motor sector 
Motor sector Motor sector 
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inhibitory effect on thalamic relay neurons (Ohara et al., 1980; Liu et al., 1995). They 
terminate onto primary, secondary and tertiary dendrites, as well as the somata of relay 
neurons (Montero, 1983; Harting et al., 1991; Liu et al., 1995; Tsumori et al., 2002). 
GABAergic neurons of the RTN exert their action onto GABAA and GABAB receptors 
expressed on thalamic relay neurons (McCormick, 1992). 
 The RTN has an important role in modulating and integrating information from 
ascending (first-order) and descending (higher-order) information that will eventually be 
processed in the cortex (Pinault, 2004; Lam and Sherman, 2007). Efferent RTN connections 
to first-order thalamic nuclei are topographically organized and usually specific to a single 
thalamic nucleus (Lam and Sherman, 2007). In contrast, input to higher-order thalamic nuclei 
is a combination of topographic projections and more complex diffuse projections from 
throughout the RTN (Lam and Sherman, 2007). The information from first-order and 
higher-order areas must interact for a clear message of the desired task to be transmitted to the 
cortex, and this message is clearly modulated by the RTN (Pinault, 2004). The RTN’s axonal 
projections that terminate in first order and higher order provide a connection for these 
thalamic nuclei, and can form thalamo-reticulo-thalamic loops. By integrating RTN axonal 
projection patterns, these loops can shape the excitation and synchronization of multiple 
thalamic nuclei therein modulating the message relayed to the cortex (Guillery and Harting, 
2003; Pinault, 2004; Lam and Sherman, 2007). 
1.1.3 General physiology of the reticular thalamic nucleus 
 Considering RTN neurons exclusively project to thalamic nuclei and have inputs from 
many areas in the brain (see above) the activity of RTN neurons is vitally important in 
optimizing the communication of messages between the thalamus and the cortex. Activity in 
RTN neurons has been extensively studied, however because the focus of this study is 
anatomical, the general electrophysiological features will be briefly explained and 
summarised below.  
 RTN neurons possess a range of different receptors that attest the range of inputs it 
receives. It also has a number of voltage-dependent ion channels that are vitally important for 
the membrane potential, firing pattern and synaptic transmission of RTN neurons. The nature 
of these receptors and ion channels endow each RTN neuron with the ability to fire in a 
specific pattern at a given moment independent of neighbouring neuronal activity; an ability 
uncommon in neuronal networks (Pinault, 2004). 
 RTN neurons are described as having 2 firing patterns that heavily depend on the 
attentional state of the animal. While the animal is awake, and actively attending to stimuli, 
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RTN neurons generally fire in a tonic state (Domich et al., 1986; Huguenard and Prince, 
1992). During slow-wave sleep however, RTN neurons exhibit a bursty firing pattern, where 
neurons rapidly fire action potentials in ‘bursts’ for a short period of time that is subsequently 
followed by a period of silence (Wallenstein, 1994; Marlinski and Beloozerova, 2014).  
 Burstiness is a firing pattern that is seen throughout the nervous system. The close 
proximity of spikes in a burst allows a stronger signal to be sent to downstream nuclei 
resulting in reliable synaptic transmission with an increased release of neurotransmitter 
(Bosch-Bouju et al., 2013). The exact purpose of bursting is still unclear. However in the 
RTN, burstiness is thought to increase the inhibitory signal to thalamic relay neurons with 
precise timing as well as synchronise the neural circuit, which is important for the 
development and maintenance of slow-wave sleep (Pinault, 2004; Marlinski and Beloozerova, 
2014). 
 Burstiness in the RTN is dependent on the low-threshold T-type calcium (Ca2+) 
channels that are present on RTN neurons (Huguenard and Prince, 1992). T-type Ca2+ 
channels underlie the low-threshold calcium spike (LTS) burst that is exhibited by RTN 
neurons. LTS bursts are characterized by a high frequency (~200 Hz) burst of spikes that 
occurs following prolonged hyperpolarisation of the membrane potential (Bosch-Bouju et al., 
2013). During prolonged hyperpolarisation of the membrane, T-type Ca2+ channels are 
de-inactivated, which allows the channel to become responsive to depolarizing events. If 
depolarization occurs following prolonged hyperpolarisation, Ca2+ ions are able to flow into 
the neuron through the now open T-type Ca2+ channel, further depolarizing the neurons and 
activating voltage-gated sodium channels and the neuron consequently fires an action 
potential. The T-type Ca2+ channel can keep the membrane potential of the cell depolarized 
for a relatively long duration, triggering multiple spikes in the LTS burst (Bosch-Bouju et al., 
2013). After a period of time, the T-type Ca2+ channel inactivates and the membrane potential 
repolarizes.  
 RTN neurons that exhibit burstiness generally have hyperpolarized membrane 
potentials compared with those that fire tonically (Brunton and Charpak, 1997). As such, 
tonically active NMDA, GABAA and mGluR2 receptors present within the RTN have 
different actions on RTN neurons (Crabtree et al., 2013). The combined effect of these 
receptors ultimately hyperpolarizes the membrane potential of RTN neurons, where tonically 
active presynaptic NMDA receptors facilitate GABA release from GABAergic terminals in 
the RTN, GABAA receptors generate a persistent chloride ion (Cl-) current that directly 
hyperpolarizes the membrane potential of RTN neurons, and presynaptic mGluR2 receptors 
reduced the glutamate release from cortical excitatory terminals (Crabtree et al., 2013). 
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Hyperpolarization of neurons increase their tendency to fire an LTS bursts following 
excitatory inputs whereas without prior hyperpolarization of the membrane potential, neurons 
will exhibit single spiking activity (Crabtree et al., 2013). 
 RTN activity is altered not only by tonically active receptors but also by the activity of 
its inputs. The major input to the RTN comes from the collaterals of corticothalamic and 
thalamocortical neurons that are glutamatergic in phenotype. Stimulation of these inputs leads 
to activation or inhibition of RTN neurons through the action of post-synaptic NMDA 
(Spreafico et al., 1988; Deleuze and Huguenard, 2016), AMPA (Deleuze and Huguenard, 
2016), and mGluR receptors (Cox and Sherman, 1999; Wang et al., 2015). Stimulation of 
thalamocortical relay neurons and corticothalamic neurons in layer VI leads to a fast 
excitatory response in the RTN mediated by ionotropic activation of AMPA and NMDA 
receptors (Gentet and Ulrich, 2003, 2004), and these responses have a long decay time, 
thought to be due to the kinetics of the NMDA receptor (Gentet and Ulrich, 2003, 2004; 
Lacey et al., 2012). It appears that AMPA and NMDA receptors alter the response to 
thalamocortical or corticothalamic stimulation differently (Deleuze and Huguenard, 2016). In 
the presence of AMPA antagonists, no excitatory post synaptic potential could be elicited in 
the RTN following corticothalamic stimulation, whereas antagonism of NMDA receptors did 
not significantly alter the response of RTN neurons, suggesting that AMPA receptors are 
important for responses to cortical excitation in RTN neurons, while NMDA receptors have a 
small component to these responses (Gentet and Ulrich, 2004). Conversely, when AMPA and 
NMDA receptors kinetics were separated with a mathematical function, NMDA receptor 
kinetics were found to play a big role in the response of RTN neurons to both cortical and 
thalamic stimulation (Deleuze and Huguenard, 2016). Thalamocortical relay neurons elicit a 
stronger excitation of RTN neurons compared with corticothalamic and both AMPA and 
NMDA receptors have large components (Gentet and Ulrich, 2003; Deleuze and Huguenard, 
2016).  
 As previously mentioned, cortically driven responses are directed mainly to the 
secondary and tertiary dendrites of RTN neurons (Liu and Jones, 1999), which may account 
for their longer lasting activations and this distal location promotes reticular cell burst firing 
via distally located T-type Ca2+ channels (Crandall et al., 2010; Deleuze and Huguenard, 
2016). Whereas thalamic inputs are targeted to proximal dendrites, which evoke large, fast 
responses in RTN neurons (Lacey et al., 2012; Deleuze and Huguenard, 2016). It is thought 
that the NMDA receptor is important in activating T-type Ca2+ receptors and driving bursty 
activity in RTN neurons following thalamic stimulation (Gentet and Ulrich, 2003). 
Furthermore, the location of these synapses suggests that strong thalamic stimulation may 
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override cortically driven responses in neurons of the rRTN, switching firing from bursty 
back to single pulses (Deleuze and Huguenard, 2016). 
 The activation of mGluRs in the RTN produces both depolarization and 
hyperpolarization based on which group of mGluR is activated (Cox and Sherman, 1999). 
Group I mGluR activation couple to Gq protein leading to the downstream activation of 
intracellular calcium stores and depolarization of RTN neurons (Neyer et al., 2016), whereas 
group II mGluR activations leads to Gi protein coupled receptor mediated hyperpolarisation 
(Cox and Sherman, 1999). The function of mGluR activation often leads to longer lasting 
changes in neurons such as long-term potentiation (group I, LTP) or depression (group II, 
LTD). LTP and LTD modulate synaptic transmission, neurotransmitter release and synaptic 
plasticity (Neyer et al., 2016), however, the role of synaptic plasticity in the RTN is yet to be 
defined. 
 The nucleus basalis, the pedunculopontine and the lateral tegmental nuclei innervate 
RTN neurons with cholinergic projections. Cholinergic projections mediate their effects 
through both nAChRs and mAChRs that have opposing effects on the membrane potential of 
RTN neurons. Activation of cholinergic afferents leads to a fast depolarization mediated 
through nAChRs that is followed by a longer-lasting hyperpolarization mediated by mAChRs 
(Beierlein, 2014). This biphasic response required the activation of T-type Ca2+ channels 
indicating that cholinergic inputs modulate the activity of RTN neurons, and act to increase 
the length of time that LTS bursts may occur (Beierlein, 2014). Cholinergic inhibition of RTN 
neurons leads to disinhibition of thalamocortical neurons allowing them to better respond to 
sensory and motor information (Harris and Thiele, 2011; Beierlein, 2014). 
 Noradrenergic stimulation of RTN neurons from the locus coeruleus acts via 
α1-adrenoceptors that are highly expressed on, and excite, RTN neurons (McCormick and 
Wang, 1991; McCormick, 1992). This excitation causes a slow depolarization of RTN 
neurons that inhibits the neuron’s ability to burst; however, smaller activation of 
noradrenergic inputs can enhance bursting activity (McCormick and Wang, 1991). Therefore 
the strength of noradrenergic input can modulate the firing pattern of RTN neurons. 
Serotonergic stimulation of RTN neurons from the raphe nucleus results in a, similarly, slow 
depolarization of RTN neurons that inhibits the burstiness of these neurons (McCormick and 
Wang, 1991; Rodríguez et al., 2011). This depolarization is indirectly mediated through a 
decrease in the outward ‘leaky’ potassium current activated by G-protein coupled receptors, 
which increases the membrane potential of RTN neurons promoting single spiking activity 
(McCormick and Wang, 1991; Rodríguez et al., 2011).  
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 GABAergic input to the RTN comes from the basal ganglia and basal forebrain. 
Intrinsic cell-to-cell GABAergic input has recently been questioned in adult rats (see Hou et 
al., 2016). GABAergic inhibition of RTN neurons is mediated through post-synaptic GABAA 
and GABAB receptors (Gentet and Ulrich, 2003; Sun et al., 2012). While GABAB receptors 
are blocked, activation of GABAA receptors leads to a depolarization of RTN neurons that is 
in part due to the low expression of the potassium-chloride transporter, KCC2, that removes 
Cl- from the cell (Sun et al., 2012). This low expression of KCC2 causes the intracellular 
levels of chloride to increase, and therefore neurons of the RTN generally have a high 
intracellular Cl- concentration leading to a positive Cl- equilibrium potential (Sun et al., 2012). 
Subsequent activation of GABAA receptors leads to a Cl- current down its concentration 
gradient and out of the cell, resulting in depolarisation (Sun et al., 2012). Furthermore, 
isolating the GABAergic synaptic input to RTN neurons can lead to bursts of action 
potentials, which is blocked with GABAA antagonism (Sun et al., 2012). T-Type Ca2+ channel 
activation was found to be critical for this GABAA mediated burstiness, where blockade of 
the low-threshold channel abolished GABA-mediated bursts of action potentials (Sun et al., 
2012). It should be noted that the above results were garnered in rats of a relatively young age 
(P13-35). Aging has a number of effects on the RTN, as well as effects on GABA 
transmission throughout the brain. Rats that are P20 exhibit GABAergic responses following 
the optogenetic activation of RTN neurons, however fail to respond at P42 (Hou et al., 2016). 
Furthermore, the expression of the KCC2 transporter increases throughout neurons during 
maturation (Ben-Ari, 2002).   
 Although limited information is available on the action of GABAB receptors on RTN 
neurons, it has been shown that activation of GABAB receptors reduces the post-synaptic 
currents evoked by GABAA receptors, and directly activates a potassium ion current leading 
to a hyperpolarisation of the resting membrane potential of RTN neurons (Ulrich and 
Huguenard, 1996). It is essential that the effects of GABA on mature adult neurons, especially 
through the activation of both GABAA and GABAB receptors, be investigated to get a better 
understanding of this nucleus. 
 Dopaminergic inputs from the SNc act via dopamine D4 receptors and modulate 
presynaptic release of GABA in the RTN.  GABAergic neurons from the basal ganglia feature 
dopamine D4 receptors on their presynaptic terminals (Erlij et al., 2012), which when 
activated by SNc inputs lead to reduced GABA release (Florán et al., 2004; Govindaiah et al., 
2010). GABAergic input from the basal ganglia and its modulation by dopamine from the 
SNc is likely to be important in the processing of motor information and will be discussed in 
more detail in Section 1.1.5. 
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 RTN neurons exclusively project to thalamocortical relay neurons. Almost all 
projections of the RTN release GABA at their target thalamic nuclei and produce a strong 
inhibitory response (Huguenard, 1998). The GABAergic response in thalamic relay neurons is 
mediated by GABAA receptors that increase Cl- conductance and GABAB receptors that 
couple to G proteins to indirectly hyperpolarise the membrane of thalamic relay cells through 
K+ extrusion (Ulrich and Huguenard, 1996; Huguenard, 1998). High frequency bursts of 
GABA release from LTS bursting RTN neurons act to hyperpolarize the thalamic relay cell 
membrane quickly through GABAA receptors and for a prolonged period of time through 
GABAB receptors, thereby switching thalamic relay cell firing from tonic to bursty 
(Huguenard, 1998; Guillery and Sherman, 2002). 
 Most inputs to RTN neurons act to hyperpolarize the membrane and increase the 
likelihood of bursting activity. Although RTN neurons are thought to be bursty during slow-
wave sleep, a small proportion of neurons exhibit bursty activity in the awake-state (Marlinski 
and Beloozerova, 2014), which is of particular importance to transmit signals to thalamic 
relay cells as the coding efficiency of bursts is much higher compared to single spikes 
(Marlinski and Beloozerova, 2014). It is, therefore, not surprising that most inputs to the RTN 
increase the likelihood of LTS bursts and also increase the likelihood of that message passing 
to thalamic relay cells. This functional control is reflected in thalamic relay cells, which 
switch their firing from tonic to bursting under the influence of RTN neurons (Huguenard, 
1998). However, during slow-wave sleep, the bursting activity of RTN neurons occurs much 
more regularly in a higher proportion of neurons and becomes rhythmic (Pinault, 2004). This 
rhythmic bursting of RTN neurons synchronises thalamocortical relays and is important in 
maintaining slow-wave sleep (Pinault, 2004). 
1.1.4 Sector organisation of the reticular thalamic nucleus 
 Most of the sensory modalities, the limbic and motor systems are represented in the 
RTN in distinct sectors. However, electrophysiological evidence suggests a small degree of 
overlap between the boundaries of adjacent sectors (Pinault, 2004). Visual, auditory, 
somatosensory, taste, and visceral sensations are all represented in the caudal RTN, whereas 
limbic and motor pathways are found in the rostral aspect. The specific thalamic nuclei and 
cortical areas that are associated with each specific RTN sector are described below. 
However, afferent projections from other locations in the brain such as the brainstem and 




 The visual sector of the RTN is located in the dorsocaudal portion of the nucleus and 
receives projections from the visually related lateral geniculate nucleus of the thalamus 
(Crabtree and Killackey, 1989; Coleman and Mitrofanis, 1996). The visual sector of the RTN 
also receives inputs from the visual areas of the cortex; these are specifically mapped, and 
closely resemble the topography of the lateral geniculate (Crabtree and Killackey, 1989). The 
visual sector has reciprocal connections back to the lateral geniculate nucleus, and has 
efferent input to the higher-order pulvinar nucleus (Ohara et al., 1980; Conley and Diamond, 
1990).   
 Represented ventrocaudally in the RTN are the auditory and somatosensory sectors. 
The auditory sector has reciprocal connections with primary auditory nucleus of the thalamus, 
the medial geniculate nucleus (Conley et al., 1991) and efferent input to the medial geniculate 
is topographic (Crabtree, 1998). The higher order auditory nucleus, the posterior nucleus, 
similarly has reciprocal connections with RTN (Conley et al., 1991). The primary auditory 
cortex in the temporal lobe has input into the auditory sector of the RTN from collateral axons 
that project to first and higher order auditory thalamic nuclei (Conley et al., 1991; Kimura et 
al., 2012).  
 The somatosensory sector has afferent input from the ventrobasal complex and the 
medial division of the posterior complex from the thalamus and from the primary 
somatosensory cortex (Lam and Sherman, 2010). Somatosensory inputs to RTN were 
somatotopic, where different parts of the body are represented by different parts of the 
somatosensory sector of the RTN (Shosaku et al., 1984). The somatosensory sector has 
reciprocal connections with the higher-order somatosensory thalamic nuclei in the posterior 
nucleus (Lam and Sherman, 2007). However the higher-order inputs to the RTN are not 
topographically defined like the first-order inputs, they are diffuse throughout the thickness of 
the RTN (Lam and Sherman, 2007). 
 Anterior to the auditory and visual sectors of the RTN lies the taste-related region. 
This sector has not been extensively studied, however, it receives input from and sends 
outputs to the thalamic taste-relay, the medial ventroposterior parvicellular nucleus (Hayama 
et al., 1994). The taste sector of the RTN also receives an input from the primary gustatory 
cortex on the insular lobe (Hayama et al., 1994). Presently, RTN connections to and from the 
higher-order nuclei of gustation have not been characterized. 
 Similarly information regarding the visceral sector of the RTN is lacking. The visceral 
sector lies next to the taste-related region and rostral to the visual sector. The RTN has 
reciprocal connections with the visceral thalamic relay, the lateral ventroposterior 
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parvicellular thalamic nucleus (Stehberg et al., 2001). The visceral sector also receives input 
from the visceral sensory area in the granular insular cortex (Stehberg et al., 2001).  
 At the very rostral pole of the RTN sits the limbic sector. Cortical innervation of the 
limbic sector comes from the cingulate and retrosplenial cortices (Lozsádi, 1994). The 
anteroventral and anteromedial thalamic nuclei have reciprocal connections with the rostral 
limbic sector of the RTN (Lozsádi, 1995), which is topographically ordered (Gonzalo-Ruiz 
and Lieberman, 1995). 
 The motor sector in the rostral portion of the RTN is of particular interest to this study 
and will be discussed in its own section below (Section 1.1.5). 
1.1.5 Motor processing in the reticular thalamic nucleus 
 The motor region of the rostral RTN (rRTN) has been poorly defined to date. The 
available data and observations from the existing literature will be summarized below. The 
anatomy and physiology of the connections to the rRTN from the motor cortex, motor 
thalamus, the basal ganglia and the brainstem will be considered. These motor-related areas 
are implicated in the pathophysiology of PD, however, the rRTN has received limited 
attention with regards to the disease. Therefore these connections to the rRTN are of 
particular focus for this thesis. 
 The primary motor cortex and the ventral anterior (VA) and ventral lateral (VL) of the 
motor thalamus innervate the rRTN with glutamatergic projections (Cicirata et al., 1990; Lam 
and Sherman, 2015). These inputs are somatotopically organized similar to the somatosensory 
sector, where movements for different parts of the body are represented in distinct subsections 
of the motor sector (Cicirata et al., 1990).  
 In rats and mice, VA and VL are generally considered histologically indistinguishable 
and will henceforth be referred to as VA/VL. Although thought of as one nucleus, VA/VL can 
be divided into basal ganglia receiving and cerebellar receiving divisions (Kuramoto et al., 
2009). Furthermore, the division innervated by the cerebellum is regarded as a first-order 
relay and the target of basal ganglia innervation constitutes a higher-order relay (Lam and 
Sherman, 2011). RTN neurons project to both of these first and higher-order relays, in a 
similar manner to their projections to first and higher order relays described in the 
somatosensory sector, where first order inputs is topographical and higher order inputs are 
more diffuse and thought to connect a range of neurons within VA/VL (Lam and Sherman, 
2007, 2015).  
 Investigation of VA/VL neuron responses following rRTN activation is limited. Lam 
and Sherman reported that rRTN stimulation in slices evoked inhibitory post-synaptic 
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currents within VA/VL relay cells (Lam and Sherman, 2015). Recent data from our lab 
confirmed that rRTN neurons fire both tonically and exhibit a LTS bursting firing pattern 
(Little, 2014), therefore it is likely that the rRTN is acting in a similar mode to other parts of 
the RTN, and modulates thalamic relay cells through inhibition, and can change their firing 
pattern from tonic to bursty.  
 Data regarding the effect of motor cortex and VA/VL thalamic relay neurons on rRTN 
activity is completely lacking. Due to the similarity of connections between motor and other 
sectors of the RTN it could be assumed that stimulation of the motor cortex leads to the 
activation of rRTN neurons via AMPA and NMDA receptors and promotes bursty firing by 
activating distally located T-type Ca2+ channels (Deleuze and Huguenard, 2016), similarly, 
VA/VL input to rRTN activates neurons via NMDA and AMPA receptors, but rather than 
promoting bursty activity, VA/VL activation would lead to powerful excitation of rRTN 
neurons (Gentet and Ulrich, 2003; Fuentealba and Steriade, 2005). 
 The rRTN receives inputs from the GPe and the SNr of the basal ganglia. Considering 
the involvement of these nuclei in motor control, it is expected that they modulate the 
projection of motor messages from the rRTN to the motor thalamus. The GPe sends a direct 
GABAergic projection to the rRTN, which arborizes profusely and primarily makes 
symmetric synaptic contact onto rRTN proximal dendrites and somata (Hazrati and Parent, 
1991; Asanuma, 1994; Kayahara et al., 1994; Kayahara and Nakano, 1998). The SNr 
innervates the rRTN, and similar to the GPe, makes symmetrical GABAergic synaptic 
contacts with dendrites and somata of rRTN neurons (Asanuma, 1994; Tsumori et al., 2000, 
2002). The SNr input is mainly to the ventral part of the rRTN and not topographic whereas 
the GPe input is topographic in nature and covers the whole portion of rRTN (Gandia et al., 
1993). Limited studies have investigated the effect of stimulating GPe or SNr inputs to the 
rRTN. When the GPe is stimulated, the activity of tonically firing neurons in the rRTN is 
decreased without inducing burst firing of rRTN neurons (Pazo et al., 2013; Villalobos et al., 
2016). In contrast, when the GPe is inhibited, firing rate of tonically active neurons in the 
rRTN increases (Villalobos et al., 2016), suggesting the GPe projection exerts a basal 
inhibition onto rRTN neurons that is potentially mediated by GABAA receptors on RTN 
neurons rather than GABAB receptors, which promote hyperpolarization and subsequent burst 
firing (Ulrich and Huguenard, 1996; Hallworth and Bevan, 2005). Similarly, SNr stimulation 
causes a decrease in the firing rate of tonically firing rRTN neurons but also inhibits the 
cortically evoked bursty activity of some rRTN neurons (Paré et al., 1990). 
 These GPe and SNr inputs also appear to be modulated by dopaminergic projections 
from the SNc. Presynaptic D4 receptors on GPe and SNr axon terminals, reduce the inhibition 
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that the GPe and SNr exert onto rRTN neurons, by inhibiting the release of GABA from these 
afferent projections (Gasca-Martinez et al., 2010; Erlij et al., 2012). 
 The rRTN also has projections to motor-related intralaminar nuclei, the parafascicular 
and the centromedian complex (Pf-CM) (Steriade et al., 1984; Cornwall and Phillipson, 
1988). These inputs to the somata and dendrites of Pf-CM neurons form symmetrical 
synapses (Tsumori et al., 2002). The Pf-CM complex in turn, projects to the rostral portion of 
the rRTN and these projections are topographic. Connections to the rRTN were mostly 
located in the ventral portion, and coming from Pf rather than CM, whose connections were 
located more caudally (Sadikot et al., 1992). Although the exact nature of Pf-CM input to the 
rRTN is yet to be studied, the Pf-CM complex sends glutamatergic inputs to GABAergic 
neurons of the striatum, and it is possible that Pf-CM glutamatergic inputs also innervate 
rRTN (Sadikot and Rymar, 2009). The rRTN output neurons that project to Pf-CM receive 
inputs from the SNr, which are thought to provide an indirect pathway from the basal ganglia 
to intralaminar motor thalamic nuclei (Tsumori et al., 2000, 2002). 
 In vivo evidence on the activity of the rRTN during movement is limited. However, a 
couple of studies examined how locomotion in environments with different complexity 
affects the activity in the rRTN of cats (Marlinski et al., 2012; Marlinski and Beloozerova, 
2014).  During sleep, most neurons of the rRTN exhibit typical ‘full scale’ bursty activity, 
however, when the cat is freely walking, or walking on a horizontal ladder, the activity of 
neurons in the rRTN changes. As mentioned previously, the motor sector of the RTN is 
somatotopically organized and this is shown in their activity while walking. During the step 
cycle of a cat, the proximal limb (shoulder), represented in dorsal rRTN, and the distal limb 
(wrist-paw), represented in ventral rRTN, are modulated by the rhythm of the stride 
(Marlinski et al., 2012). The magnitude of this modulation and the tendency of RTN neurons 
to fire in bursts was higher for distal compared with proximal limb neurons. The difference in 
activity in RTN neurons transfers to an increased inhibition of thalamic neurons that are 
within the distal limb domain (Marlinski et al., 2012). This suggests that the pattern of rRTN 
neuron activity ensures that motor signals from the different parts of the limb arrive at the 
motor cortex with appropriate temporal precision (Marlinski et al., 2012), that is, during a step 
the distal limb representation in the rRTN is sending a strong bursty signal to the motor 
thalamus ensuring that the motor signal arrives at the cortex with precise timing to guarantee 
accurate placement of the paw. 
 Burstiness while walking freely or in a complex environment changes from a 
‘full-scale’ burst that typically appears during sleep, which show an acceleration to maximal 
firing rate and then decelerate until the end of the bursty episode, to an atypical bursty pattern 
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that feature short initial bursts that start at their maximal firing rate followed by a 
characteristic deceleration phase (Marlinski and Beloozerova, 2014). The likelihood that 
bursty activity would occur did not differ between simple and complex environments, 
however the pattern that the bursty neurons exhibited changed. Walking on a horizontal 
ladder requires accurate placement of the paw with each step. During this complex task, the 
atypical short bursty pattern was more frequently observed in neurons of the rRTN compared 
with just walking freely (Marlinski and Beloozerova, 2014), suggesting that these changes in 
burst pattern allows brief, but temporally aligned, inhibition of the thalamic neurons, which is 
tuned to the pattern of the stride. Therefore, at the end of the stride, activity in the 
thalamocortical circuit is attenuated by intense episode of maximally firing burstiness in the 
rRTN, which ensures the command signal for the next step is relayed to the motor cortex 
without interference from other thalamocortical motor circuits (Marlinski and Beloozerova, 
2014). 
 It seems likely that the motor cortex, motor thalamus and the motor sector of the RTN 
work in unison to ensure that the most appropriate motor signal is conveyed through the 
thalamocortical and corticothalamic circuits, so that smooth and accurate movements occur. 
While there is a current lack of in vivo evidence on the effect that other motor areas of the 
brain, such as the basal ganglia, have on the activity of rRTN and how that transfers to motor 
performance, it is likely that disruption of these signals will contribute to the pathophysiology 
of motor diseases such as PD. 
1.2 Parkinson’s disease 
1.2.1 Parkinson’s disease overview 
 PD is one of the most common neurodegenerative disorders in the world. It is a 
disease that mostly affects the elderly, and has no cure. Parkinson’s is characterised by four 
cardinal symptoms that are all motor related; bradykinesia or the slowness of movement, and 
akinesia or impairment of voluntary movement, tremor at rest most often occurring in distal 
limbs, rigidity or increased resistance in moving a limb, which may be accompanied by pain, 
and postural instability or abnormal posture (Bloem, 1992; Parkinson, 2002; Jankovic, 2008).  
 PD is initially caused by the loss of dopaminergic neurons in the SNc and VTA (Fahn 
et al., 1971; Uhl et al., 1985). Motor symptoms, however, are not experienced until 
approximately 70% of dopaminergic neurons in the SNc have been depleted (Fearnley and 
Lees, 1991). A number of patients with Parkinson’s also experience non-motor cognitive 
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symptoms such as sleep disorders, mild cognitive impairment, dementia, and depression 
(Factor et al., 1990; Tandberg et al., 1998; Aarsland et al., 2001, 2003; Levy et al., 2002; 
Remy et al., 2005; Caviness et al., 2007; Yarnall et al., 2013). 
 Currently, PD affects approximately 2% of the population aged 65 and older, leading 
to an estimated 13000 people with PD in New Zealand (Statistics New Zealand 2016; 
Aarsland et al., 2001, 2003). This number is expected to double in the next 25 years due to the 
increasing age of the general population (Kowal et al., 2013).  
 Oral administration of the dopamine precursor levodopa (L-DOPA) remains the gold 
standard treatment for PD and is effective in relieving most of the motor symptoms of the 
disease (Cotzias et al., 1967; Jankovic, 2008). However, the efficacy of L-DOPA varies 
between patients, the plasma levels of L-DOPA fluctuates so that patients exhibit so called 
“ON/OFF” effects, where motor symptoms return during the “OFF” period (Jankovic and 
Aguilar, 2008). Long-term treatment with L-DOPA narrows the therapeutic window of 
L-DOPA and causes dyskinesias and involuntary movements, which in themselves are 
disabling (Jankovic and Aguilar, 2008; Poewe, 2009). Furthermore, L-DOPA is not effective 
against the non-motor symptoms of PD (Poewe, 2009).   
 Before the clinical application of levodopa, surgical ablation of the thalamus was the 
standard treatment for PD, however these were not effective in treating all the motor 
symptoms of PD and came with a number of complications in surgery and morbidity 
(Benabid et al., 1987; Poewe, 2009). Another surgical practice that is effective in treating the 
motor symptoms is deep brain stimulation (DBS), which can be used to treat patients who are 
refractory to L-DOPA treatment of those who are experiencing uncomfortable dyskinesias 
due to chronic drug treatment. (Benabid et al., 1987; Sprenger and Poewe, 2013). The 
subthalamic nucleus (STN) or the internal segment of the GP (GPi) are the most common 
targets for DBS, and electrical stimulation of these areas results in an improvement of motor 
symptoms (Poewe, 2009). However, DBS is an invasive therapy that can have a number of 
surgical complications, such as haemorrhage, and the electrical stimulation of the brain has 
effects on neuropsychological functions resulting in confusion, apathy and depression (Voon 
et al., 2006; Poewe, 2009; Sprenger and Poewe, 2013).  
 Emerging treatments are beginning to target non-dopaminergic pathways, such as 
glutamatergic NMDA receptor antagonists, and gene therapy, such as GAD gene therapy in 
the STN, is a promising treatment that has shown a reduction in L-DOPA related motor 
fluctuations in patients with no adverse side effects shown thus far (Kaplitt et al., 2007; 
LeWitt et al., 2011; Stayte and Vissel, 2014). 
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1.2.2 Animal models of Parkinson’s disease 
 To further our understanding of the pathogenesis of PD, as well as discover novel 
therapeutic strategies, use of animal models offers a substrate to explore in vivo changes that 
may occur due to the disease. Although clinical data can be obtained from in vitro slices and 
post-mortem tissue of humans patients with PD, the in vivo changes that occur, prior to and 
during PD are crucial not only to optimise treatments for PD but also in the early detection 
and prevention of the disease.  
 Models of PD should meet several criteria that define Parkinson’s in patients. First 
and foremost dopaminergic neurons should be depleted to a degree that matches that of 
human patients (> 50%) and the cardinal symptoms that patients develop, such as the 
hallmark motor deficits, should be displayed in the animal model (Hirsch et al., 2003). Other 
desirable characteristics that could be modelled but are not essential are lesions to 
non-dopaminergic populations of neurons that are often evident in late-stage PD of humans, 
and the presence of alpha-synuclein containing Lewy bodies, which are present in patients 
with PD but are not specific to the disease and are found in other neurodegenerative diseases 
such as Alzheimer’s disease (Dauer and Przedborski, 2003).  
 Animal models of PD can be divided into a two broad categories; genetic models, that 
manipulate genes that have been related to PD and neurotoxic models, that may represent 
environmental risk factors which induce PD. However other models do exist, such as the 
intraparenchymal infusion of alpha-synuclein oligomers to induce Lewy bodies (Porras et al., 
2012) and the use of pharmacological compounds to acutely antagonize dopaminergic 
transmission in the striatum such as haloperidol (Parr-Brownlie and Hyland, 2005; Seeger-
Armbruster et al., 2015). The neurotoxic model is most commonly used, has been thoroughly 
studied, and is the specific focus of this section.  
 The two most frequently used neurotoxins to induce dopaminergic lesions are 
6-hydroxydopamine (6-OHDA), and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). 
The pesticide rotenone is also frequently used to model PD. Each will be discussed below. 
 6-OHDA The neurotoxin 6-OHDA has been used to lesion dopaminergic neurons in 
the SNc for nearly 50 years (Ungerstedt, 1968). The VTA is also affected by 6-OHDA lesions 
but to a lesser degree than the SNc (Tseng et al., 2005). It is most frequently used in rats, 
however mice, non-human primates and other species can be made parkinsonian with 
6-OHDA (Betarbet et al., 2002). The toxin does not cross the blood brain barrier, so is 
stereotaxically injected directly into the brain usually unilaterally, although bilateral injections 
do occur (Bové and Perier, 2012; Le et al., 2014). Due to its structural similarity to 
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catecholamines, 6-OHDA is taken up by catecholinergic neurons, such as dopaminergic and 
noradrenergic neurons, by a catecholamine transporter (Bové and Perier, 2012). Therefore to 
be selective for dopaminergic depletion, it is used in conjunction with a nor-adrenaline 
re-uptake inhibitor such as desipramine to protect noradrenergic neurons (Waddington, 1980). 
Once in the neuron, 6-OHDA accumulates in the cytoplasm and undergoes auto-oxidation 
yielding two toxic products, hydrogen peroxide and paraquione, which cause cell death (Le et 
al., 2014).  
 Following bilateral injections, rats are unable to look after themselves due to the 
severity of the lesion and must be intensively nursed. Therefore, unilateral injections are the 
most popular model (Blesa et al., 2012). 6-OHDA can be injected into the SNc itself, the 
striatum and the medial forebrain bundle (MFB), which is a bundle of nigral dopaminergic 
fibres ascending to the striatum (Le et al., 2014). When injected into the SNc and MFB 
dopaminergic neurons begin to degenerate within 24 hours (Jeon et al., 1995), however, 
retrograde degeneration takes 1-3 weeks when injected into the striatum (Przedborski et al., 
1995). Following MFB injections, the dopaminergic content in the striatum is less than 20% 
after 3-4 days and the number of dopaminergic neurons in the SNc continues to decrease for 
up to 5 weeks (Bové and Perier, 2012). If a successful lesion has occurred, up to 90% of 
dopaminergic neurons will be lesioned in SNc (Bové and Perier, 2012).  
 Behaviour tests offer a quick in vivo check of unilateral lesion status with motor 
performance compared between paws. The non-lesioned hemisphere acts as a control, 
however, sham-lesioned rats should also be used as a more complete control for experiments 
(Hirsch et al., 2003). Rats will exhibit asymmetric rotations, as well as reduced motor activity, 
and preference for the unlesioned paw (Olsson et al., 1995; Vandeputte et al., 2010; Bové and 
Perier, 2012). Rotational behaviour can also be induced in unilateral lesioned rats by injecting 
a dopaminergic agonist, such as apomorphine, or drug that releases the remaining dopamine 
(e.g. amphetamine) that will cause rotations in the contralateral (away from the lesion) or 
ipsilateral (toward the lesion) directions, respectively (Ungerstedt and Arbuthnott, 1970). 
Following injections into the striatum, rats have also exhibited some non-motor symptoms of 
PD such as anxiety and depression, as well as gastrointestinal dysfunction (McDowell and 
Chesselet, 2012).  
 The behaviour of animals can be recovered with L-DOPA treatment, however, chronic 
long-term L-DOPA treatment leads to abnormal involuntary movements or dyskinesias, 
similar to human patients and indeed, this model has been used in the study of dyskinesias 
(Carey, 1991; Henry et al., 1998; Winkler et al., 2002; Smith et al., 2016). High frequency 
(≥130 Hz) DBS has also proved effect in the 6-OHDA model of PD, where symptoms of PD 
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were alleviated and neuronal transmission in the basal ganglia was recovered (Spieles-
Engemann et al., 2010; So et al., 2012; Dorval and Grill, 2014). 
 Although 6-OHDA does not produce Lewy-body like neuronal inclusions and 
injections into the MFB acutely degenerate dopaminergic neurons, it is a highly reproducible 
model, and rats exhibit many of the symptoms that occur in patients with PD. It is widely 
used to study the pathophysiological changes that occur within the brain under 
parkinsonian-like conditions and it is with this in mind that the 6-OHDA model of PD was 
used in this study.  
 MPTP The neurotoxin MPTP was first discovered to induce symptoms, remarkably 
similar to Parkinsonism, in humans in the 1980s (Langston et al., 1983). Following this 
discovery, it was quickly adapted into animals as a model of PD. MPTP is most often used in 
non-human primates and mice but rats are relatively resistant to MPTP lesion (Chiueh et al., 
1984). MPTP is usually administered systemically, will readily cross the blood-brain barrier 
and induce a bilateral lesion of dopaminergic neurons (Betarbet et al., 2002). MPTP can also 
be infused into the internal carotid on one side inducing a unilateral lesion that does not cause 
a complete destruction of the dopaminergic system and therefore animals are able to feed, 
drink, groom and maintain themselves (Blesa et al., 2012). Once MPTP is in the brain it 
enters astrocytes and is converted into its active metabolite 1-methyl-4-phenylpyridine 
(MPP+) by the enzyme monoamine oxidase B (Nakamura and Vincent, 1986). MPP+ is then 
released by the astrocytes and selectively taken up by dopaminergic neurons in the SNc due to 
its affinity with the dopamine transporter. MPP+ inhibits complex I of mitochondrial function 
subsequently leading to death of dopaminergic neurons through oxidative stress (Langston et 
al., 1983). Indeed, in patients with PD, systemic expression of complex I activity is reduced 
(Schapira et al., 1989), suggesting a similar mechanism between MPP+ and the pathogenesis 
of PD. Other neurotransmitter systems are sensitive to MPTP intoxication such as the 
noradrenergic and serotonergic systems, which are also affected in late-stage PD (Hirsch et 
al., 2003).  
 Non-human primate models of PD present with the hallmark symptoms of 
bradykinesia, rigidity, abnormal posture, and sometimes tremor (see Le et al., 2014) that 
closely mimic the human form of the disease. MPTP lesion is influenced by the age and 
gender of the primate model and can produce variable results. Motor symptoms improve with 
L-DOPA drug treatment, however dyskinesias may develop with prolonged treatment, similar 
with human patients (Blesa et al., 2012), and DBS stimulation of the STN or GPi relieve 
motor deficits associated with this model of PD (Benazzouz et al., 1993; Hahn et al., 2008; 
Tass et al., 2011). In some species of monkeys, non-motor symptoms of PD appear, such as 
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sleep disorders (Verhave et al., 2011), attention deficits and decision-making dysfunction (Le 
et al., 2014). However, MPTP administration in non-human primates is most often acute, and 
therefore does not mimic the slow progressive decline of PD over time. Chronic lower-doses 
of MPTP administration have been used but due to the time and cost of maintaining primate 
models it is used sparingly (Le et al., 2014). Furthermore, following chronic small-doses of 
MPTP motor symptoms reduce when treatment stops suggesting it may not progress to 
PD-like degeneration (Betarbet et al., 2002).  
 Mice models have been used more regularly than primate models, usually due to the 
lower financial cost, however, mouse strains differ in their susceptibility to the neurotoxin 
(Betarbet et al., 2002; Le et al., 2014). Motor symptoms in mice are not as characteristic as in 
the primates and in some cases mice become hyperactive following MPTP administration 
(Hirsch et al., 2003). These contradictory results may be due to the varying sensitivity of the 
mice to the toxin. Chronic exposure to MPTP in mice has led to the development of Lewy 
body-like inclusions and mice develop motor deficits as a result of dopamine depletion 
(Meredith et al., 2008). 
 MPTP does not work in rats, and although it represents a good model of PD in 
non-human primates and mice with acute and chronic exposure, there is a great financial and 
time cost to the primate models and it is variable with the strain of mouse used. Bilateral 
degeneration requires intensive post-lesion care but remains a standard toxin model of PD in 
mice and primates. MPTP was not used for this project because rats are the model species.  
 Rotenone This natural cytotoxic compound is extracted from tropical plants and is 
systemically administered most commonly in rats, however, monkeys have been used 
(Mastroberardino et al., 2009). It is highly lipophilic and readily crosses the blood brain 
barrier where it binds to and inhibits mitochondrial complex I much like MPP+ and at low 
doses has been shown to selectively degenerate dopaminergic neurons in the SNc (Betarbet et 
al., 2000; Dauer and Przedborski, 2003). Following administration of rotenone, animals 
develop abnormal posture, unsteady gait and bradykinesia, and can sometimes induce 
Lewy-body-like cytoplasmic inclusions that are alpha-synuclein positive. Rotenone can also 
be stereotaxically injected in the MFB and elicits dopaminergic lesions in the SNc that is 
associated with PD-like motor symptoms that are reversed with L-DOPA (Alam et al., 2004). 
However, rotenone lesions are a labour-intensive process, and is highly variable (Betarbet et 
al., 2002). Reproducibility of rotenone-induced lesions has been questioned, and has been 
found to lesion dopaminergic neurons and non-dopaminergic populations, suggesting a model 
of late-stage idiopathic PD (Höglinger et al., 2003). Not all strains of rats are sensitive to the 
toxin (Betarbet et al., 2000). Systemic administration of rotenone can also lead to a high 
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mortality rate of animals (Le et al., 2014), and similar to MPTP and 6-OHDA, bilateral 
injections leave the animal extremely sick and are difficult to maintain (Betarbet et al., 2002).  
 Rotenone appears to be a reasonably accurate model of Parkinson’s, especially 
late-stage PD, and with the appearance of dopaminergic, and non-dopaminergic lesions and 
neuronal inclusions rotenone induced PD remains a relevant model to study neuroprotective 
therapies. Although this may be useful to alleviate symptoms of patients with PD, it does not 
add to the early detection and prevention of PD. However, due to its difficult protocol and 
high variability, rotenone neurotoxicity was not used in this study. 
1.2.3 Circuitry of the basal ganglia and Parkinson’s disease  
 Overview The basal ganglia are a group of nuclei that are intimately involved in the 
planning and initiation of movements. They include the striatum, the GPi and GPe, the STN, 
the VTA and both the SNr and SNc (Beckstead et al., 1979; Albin et al., 1989). The basal 
ganglia are functionally connected with the motor cortex, the supplementary motor area and 
the motor portion of the thalamus including the VA/VL and the ventromedial (VM) nuclei, to 
make a cortico-basal ganglia-thalamocortical loop (Albin et al., 1989). The striatum receives 
inputs from most areas of the cortex (Albin et al., 1989) as well as a dopaminergic projection 
from the SNc and the VTA (Beckstead et al., 1979; Burns et al., 1983), and projects to the 
basal ganglia output nuclei, GPi and SNr, via two pathways, the ‘direct’ and the ‘indirect’ 
pathway, which will be discussed below (DeLong, 1990). The GPi and SNr send messages to 
the motor thalamus that in turn sends messages to the cortex, which are modulated by the 
RTN (Figure 1.4). Messages are then conveyed down the brainstem and spinal cord to 
innervate alpha motor neurons resulting in movement (Parent and Hazrati, 1995). The loss of 
dopaminergic neurons in the brain associated with PD has various pathological effects on the 
nuclei of the basal ganglia, and will be discussed in this section.  
 Anatomy As the name suggests, the ‘direct’ pathway is a direct projection from the 
striatum to the SNr/GPi. The indirect pathway involves a projection from the striatum to the 
STN, through a relay in the GPe, and a projection from the STN to the SNr/GPi. The SNr/GPi 
have output projections to the motor thalamus (VA/VL and VM) (Albin et al., 1989, DeLong, 
1990). Dopaminergic projections from the SNc and the VTA modulate the incoming 
information from the cortex by differently affecting the output pathways of the striatum 
(Beckstead et al., 1979, Burns et al., 1983).  Figure 1.4 shows the general connections of the 
basal ganglia that will be discussed in detail below where in each case, ‘normal’ anatomy is 
considered first followed by the changes that occur with dopaminergic depletion. 
 
 27 
 The output neurons of the striatum, called medium spiny neurons (MSNs) are 
inhibitory GABAergic neurons that can be classed into two sub-populations based on the 
expression of the neuropeptides, substance P and enkephalin (Gerfen et al., 1990). In addition, 
the striatum also contains at least three classes of interneurons; cholinergic interneurons, 
parvalbumin interneurons and somatostatin interneurons (Kawaguchi, 1997). The focus for 
this section will be on the output GABAergic MSNs. Cortical afferents to MSNs are 
glutamatergic and synaptic input is to the head and shaft of dendritic spines (Parent and 
Hazrati, 1995). MSNs of the direct pathway express substance P and dopaminergic 
modulation from the SNc and VTA is via D1-receptors whereas those of the indirect pathway 
projecting to the GPe express enkephalin and dopamine binds to D2-receptors (Gerfen et al., 
1990; Surmeier et al., 2007). Dopaminergic depletion following PD results in a loss of 
dendritic spines on MSNs that decreases the surface area for cortical synaptic input and 
disrupts normal motor activity (McNeill et al., 1988; Stephens et al., 2005; Villalba et al., 
2009; Villalba and Smith, 2010). PD also decreases D1-receptor expression and increases 
D2-receptors (Gerfen et al., 1990) resulting in abnormal modulation of striatal activity, again 
disrupting activity in the basal ganglia-thalamocortical pathway.  
 
Figure 1.4. Connectivity of basal ganglia nuclei and the RTN. Red arrows represent 
inhibitory projections, green arrows represent excitatory projections and blue arrows represent 




 Striatal input into the GPi/SNr via the direct pathway is GABAergic, and makes 
numerous synaptic contacts with dendrites and somata of GPi/SNr neurons (Bevan et al., 
1994a, 1994b). Striatal innervation of the GPi/SNr is dense and directed to neurons that 
subsequently project to the motor thalamus (Bevan et al., 1994a). Similarly, striatal input 
through the indirect pathway is GABAergic. MSN output neurons densely innervate all parts 
of GPe neurons that project to the STN (Smith et al., 1998). The evidence regarding changes 
in striatal input to the GPi/SNr and GPe is divided. In rodent animal models of PD, only 
striatal input through the indirect pathway is affected (Ingham et al., 1997), whereas in 
primate models of PD, both direct and indirect pathways are affected (Ingham et al., 1998; 
Villalba et al., 2009). In either case, loss of spines is apparent in striatal inputs to the GPi/SNr 
or GPe (Villalba and Smith, 2010). The expression of the GABA synthesising enzyme GAD 
with the molecular weight of 67 kDa (GAD67) correlates to GABAergic activity of any 
particular neuron (Lau and Murthy, 2012). The expression of GAD67 in the striatum differs 
between subpopulations of striatal neurons where MSN output neurons generally have low 
expression of messenger ribonucleic acid (mRNA) that code the enzymes GAD67 and 
GABAergic interneurons have a high expression (Soghomonian et al., 1992; Laprade and 
Soghomonian, 1999). Following dopaminergic depletion, GAD67 mRNA expression in MSN 
output neurons is increases, whereas, in GABAergic interneurons it decreases (Soghomonian 
et al., 1992; Laprade and Soghomonian, 1999). These findings indicate that GABAergic 
synaptic transmission of striatal output neurons is altered and GABAergic transmission within 
the striatum itself is also changed (Soghomonian et al., 1992; Laprade and Soghomonian, 
1999; Lau and Murthy, 2012). Furthermore, GABAergic transmission in the GPi/SNr is 
altered (Galvan and Wichmann, 2008), with an increased number of GABA receptors that are 
thought to account for the reduced GABAergic input from the striatum (Griffiths et al., 1990; 
Chadha et al., 2000; Katz et al., 2005). Whereas in the GPe, decreased numbers of 
GABAergic receptors indicate overactive GABAergic inputs from the striatum (Griffiths et 
al., 1990; Chadha et al., 2000; Katz et al., 2005).  
 Along the indirect pathway, GPe projections to the STN are topographically organized 
and input is made by symmetrical contacts onto proximal dendrites and somata (Smith et al., 
1990). The GPe projection is GABAergic and makes numerous contacts with a STN neuron 
by ‘wrapping’ itself around its target neuron and synaptic varicosities provide multiple sites 
of synaptic transmission (Smith et al., 1990). Following depletion of dopamine, GABA 
release in the STN is decreased (Soares et al., 2004), presumably as a consequence of 
overactive striatal inputs into the GPe. In contrast to this, the amount of GAD67 mRNA per 
neuron and the number of neurons in the GPe that express GAD67 mRNA was increased 
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following 6-OHDA lesions that would indicate increased GABAergic transmission (Kincaid 
et al., 1992; Soghomonian and Chesselet, 1992; Lau and Murthy, 2012). It is suggested that 
the activity pattern of GPe neurons (discussed below), which changes with dopaminergic 
lesions, is critical in the regulation of GAD67 mRNA expression (Soghomonian and 
Chesselet, 1992). 
 The STN projects to the output nuclei with asymmetric contacts with distal and 
proximal dendrites and somata (Bevan et al., 1994a, 1997). STN input is glutamatergic and 
convergent on GPi/SNr neurons that are projecting to the motor thalamus (Bevan et al., 
1994a). In animal models of Parkinson’s, glutamatergic receptors are down regulated in the 
GPi/SNr presumably as a result of increased STN activity (Galvan and Wichmann, 2008). 
 The GPi/SNr output neurons are GABAergic, and densely innervate the motor 
thalamic nuclei, VA/VL and VM. Input from both GPi and SNr make synaptic contact onto 
the proximal dendrites and somata of thalamic neurons (Kha et al., 2000, 2001; Bodor et al., 
2008). There is limited evidence regarding anatomical changes to this input, and most studies 
investigate the changes in activity of these basal ganglia output neurons, which will be 
summarised below. However, the levels of GAD67 expression in GPi and SNr projection 
neurons have been found to be increased in PD (Rodríguez Díaz et al., 2003; Conte-Perales et 
al., 2011), suggesting an increase in GABAergic signalling by these output nuclei.  
 Physiology Below, the physiological properties and firing patterns of the basal ganglia 
will be discussed with the normal activity considered first, followed by the changes that occur 
during PD. The pathophysiology of Parkinson’s is primarily thought to be due to 
abnormalities that arise in the basal ganglia. Generally, dopamine depletion in the SNc and 
VTA change the activity and firing pattern of neurons throughout the basal ganglia leading to 
an over-inhibition of the motor thalamus and results in the poverty of movement commonly 
seen in patients with PD (Galvan and Wichmann, 2008). 
 Physiological striatal activity can be difficult to characterize due to the heterogeneous 
population of MSNs in the striatum (Galvan and Wichmann, 2008). Focusing on striatal 
MSNs, activity of these output neurons is GABAergic and continuous at a low frequency, 
with rare episodes of burstiness (Dehorter et al., 2009). As stated earlier, burstiness is an 
important pattern for the communication between neuronal groups, and changes in the pattern 
of bursty activity can have an impact on downstream events (Bosch-Bouju et al., 2013).  In 
dopamine depleted slices of MSNs, GABAergic currents shift from a low continuous drive, to 
giant spontaneous activity, occurring in single spikes as well as in bursts that changes the 
pattern of activity in the striatum from tonic to oscillatory (Walters et al., 2007; Dehorter et 
al., 2009). Currently there is little in vivo evidence of the changes to subpopulations of striatal 
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activity, however in 6-OHDA lesioned animals, direct pathway MSNs were found to have 
reduced activity than normal, and indirect pathway MSNs had increased discharges compared 
with normal (Mallet et al., 2006). Changes in activity in the striatum may affect the balance 
between the direct and indirect pathways and lead to downstream changes in the whole basal 
ganglia network. 
 The GPe, GPi, SNr and STN have similar tonic activity, and will be discussed together 
(Miller and DeLong, 1987; Filion and Tremblay, 1991; Walters et al., 2007; Galvan and 
Wichmann, 2008). Under normal physiological conditions, these nuclei display tonic 
discharges at a high frequency, however, some neurons of the GPe will exhibit pauses in 
activity (Miller and DeLong, 1987). In PD, the rate of firing changes in most of these nuclei 
(Miller and DeLong, 1987; Avila et al., 2010), which has consequences on the output from 
the basal ganglia to the thalamus. Following loss of dopamine, the firing rate in the GPi, and 
STN is increased (Miller and DeLong, 1987; Filion et al., 1988; Tremblay et al., 1989; Filion 
and Tremblay, 1991; Bergman et al., 1994; Rothblat and Schneider, 1995; Delaville et al., 
2015), whereas in the GPe, the firing rate decreases (Miller and DeLong, 1987; Tremblay et 
al., 1989; Filion and Tremblay, 1991). The changes to the firing rate of SNr are controversial, 
some studies have found no changes in primate models of PD (Wichmann et al., 1999), 
however, increased firing in SNr has been observed 21-days post induction of PD in a rodent 
model of the disease (Avila et al., 2010). Under dopamine-deprived conditions, the GPi/SNr 
are released from their inhibition along the direct pathway, and are further activated by the 
disinhibited STN, causing over-inhibition of the motor thalamus. Consequently, relay of 
motor messages from the motor thalamus to the cortex becomes inhibited, leading to the 
classical motor symptoms of PD (Galvan and Wichmann, 2008).  
 Rate of firing is not the only change that occurs with PD. The GPe, GPi, SNr and STN 
demonstrate changes in their firing patterns, where bursty events and oscillations become 
more frequent. These nuclei all exhibit burst discharges normally (Miller and DeLong, 1987; 
Beurrier et al., 1999; Wichmann et al., 1999) which are a transient cluster of spikes and 
usually specifically timed to an event of physiological relevance, such as a motor task (Lobb, 
2014; Marlinski and Beloozerova, 2014). In PD, the pattern of bursting activity of these 
nuclei become abnormal where the likelihood of bursty activity is increased and individual 
bursts of spikes are more persistent (Miller and DeLong, 1987; Filion and Tremblay, 1991; 
Parr-Brownlie et al., 2007). These bursts are either irregular or oscillatory in nature 
(Hammond et al., 2007). Oscillatory activity occurs in individual neurons as well as in 
neuronal populations and is thought to be important for the communication of messages 
within the brain (Galvan and Wichmann, 2008). Oscillatory activity in PD occurs in an 
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abnormal rhythm within the basal ganglia, and often pathologically synchronizes the nuclei 
together (Hammond et al., 2007; Quiroga-Varela et al., 2013). When synchronization does 
occur in a normal state, it is transient while the motor message is passed through the basal 
ganglia loop, however in PD, this synchronization becomes stable, therefore it persists and is 
thought to impair the motor message that is conveyed (Hammond et al., 2007).  
 The basal ganglia nuclei are extremely important in the proper generation and 
execution of movements. Normally they work in harmony with the thalamus and cortex to 
ensure normal development of the motor programme, and the dopaminergic system regulates 
this activity. When dopamine is depleted in the basal ganglia, changes in physiological 
properties including firing rate and firing pattern, disrupt the message that will be conveyed 
through this network, and impairs movement. 
1.2.4 Parkinson’s disease and the reticular thalamic nucleus 
 The rRTN is perfectly situated to regulate the motor information going from the 
thalamus to the cortex. Considering that the RTN is involved in the generation of sleep 
spindles, and patients with PD frequently have problems with sleep (Factor et al., 1990), it is 
easy to see how the RTN could be implicated in the pathophysiology of this disease. 
Furthermore, excitotoxic lesions of the RTN with domoic acid is associated with attention 
deficits, and 6-OHDA lesions of the dopaminergic input to the RTN results in schizophrenia, 
and reduced motor activity, which patients with Parkinsonism may experience (Friedberg and 
Ross, 1993; Picazo et al., 2009). 
 The rRTN receives projections from the SNr and both the GPi and GPe that have been 
defined anatomically and physiologically in Sections 1.1 and 1.2.3 (see also Figure 1.4). The 
motor sector of the RTN also projects to VA/VL in the motor thalamus and should therefore 
be considered in basal ganglia-thalamocortical circuitry. The physiological characteristics of 
neurons in the rRTN are similar to the basal ganglia nuclei. Generally RTN neurons fire with 
relatively low tonic activity, compared with the high tonic activity in the GPe, GPi, SNr and 
STN, and some neurons of the rRTN demonstrate transient bursty activity similar to basal 
ganglia nuclei (Domich et al., 1986; Spreafico et al., 1988; Marlinski and Beloozerova, 2014).  
 The investigation into how PD affects the RTN is incomplete, however, the few 
changes that have been found will be described below. Following 6-OHDA lesions in the 
SNc, expression of GAD67 in rRTN is increased (Delfs et al., 1996), similar to increased 
expression of GAD67 in the striatum, GPe, GPi, and SNr (Soghomonian and Chesselet, 1992; 
Soghomonian et al., 1992; Delfs et al., 1995; Rodríguez Díaz et al., 2003; Conte-Perales et al., 
2011), and indicates that GABA transmission in the RTN is altered (Delfs et al., 1996; Lau 
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and Murthy, 2012). Additionally, dopamine content within rRTN is decreased following 
depletion of dopaminergic neurons in the SNc (Anaya-Martinez et al., 2006), possibly causing 
an increase of transmitter release by GABAergic terminals from the GPe and SNr, which is 
normally modulated by presynaptic D4 receptors (Florán et al., 2004; Govindaiah et al., 2010; 
Erlij et al., 2012). A small decrease of dopaminergic neurons in the SNc and subsequent loss 
of dopaminergic innervation to the rRTN has also led to reduced motor activity and 
anxiety-related behaviours in the open-arm maze, however no affect was seen on rota-rod 
performance, possibly due to the small size of the dopaminergic lesion (Picazo et al., 2009).  
 Recent data reported in a thesis from this lab indicates that with 6-OHDA lesions of 
the SNc and VTA, the firing rate of rRTN neurons is decreased and the firing pattern of 
neurons in the rRTN becomes more frequently bursty (Little, 2014), again, similar to changes 
seen in basal ganglia neurons.  
 The RTN is a nucleus that is not normally considered important in basal ganglia 
function. However with its close anatomical and physiological link with a lot of the basal 
ganglia nuclei, it is very likely that the RTN plays a role in some of the symptoms of PD such 
as motor deficits, attention deficits or sleep disorders (Factor et al., 1990; Tandberg et al., 
1998; Aarsland et al., 2001; Levy et al., 2002; Remy et al., 2005; Caviness et al., 2007; 
Yarnall et al., 2013). 
1.3 Viral vector labelling of neurons 
1.3.1 History of anatomical tracing methods 
 To understand fundamental aspects of disorders of the brain such as PD, it is essential 
to know how neurons connect and communicate with each other. Neuronal tracing allows us 
to look at the anatomy of connections, either the inputs to a particular area of interest or the 
target structures the area innervates. This mapping allows for detailed descriptions of 
neuronal projections that can reveal circuits within structures in the brain, such as the basal 
ganglia circuitry. Technology has massively advanced the ability to assess interconnections of 
neural systems and with the latest viral vector technology, we are able to selectively label a 
specific phenotype of a neuron, at a specific injection site within the brain and get substantial 
amplification of the signal that is easily detected. The history of anatomical tracing methods 
will briefly be summarised below. 
 Ramon y Cajal first pioneered anatomical descriptions of neuronal morphology and 
tract tracing with the Golgi impregnation method in the late 1800s and early 1900s (Lanciego 
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and Wouterlood, 2011). Although now considered coarse, Golgi staining paved the way to 
better and more specific methods of tract tracing. Utilising the uptake of macromolecules into 
neurons and their transportation within the neurons, tracers can be used to label the entire 
length of a cell from the soma to distal axon terminals (Kristensson et al., 1971). 
Transportation can either occur retrogradely, from the axon terminals towards the cell soma, 
or anterogradely, from the cell soma to the axon terminals. Neuroanatomical tracers can be 
stereotaxically injected into a desired area of the brain allowing a specific location to be 
targeted. Mechanical injection into the brain can cause damage of fibres of passage and 
uptake of tracers by these damaged neurons (Lanciego and Wouterlood, 2011). Whereas 
iontophoretic delivery limits this damage (Lanciego and Wouterlood, 2011). However, only 
small quantities of tracer can be delivered with this method, and not all tracers are compatible 
with iontophoretic delivery (Lanciego and Wouterlood, 2011).  
 The popular retrograde tracer horseradish peroxidase (HRP) has been used since the 
1970s (Kristensson and Olsson, 1971). HRP is taken up in the axons and dendrites of neurons 
as well as at the cell body (LaVail and LaVail, 1972). The mechanism by which this happens 
makes HRP susceptible to being taken up by damaged axons and fibres of passage and, 
therefore, can label neurons away from the injection site (Lanciego and Wouterlood, 2011). 
HRP can be conjugated to the lectin, wheat germ agglutinin (WGA) and the bacterial 
non-toxic B fragment of cholera toxin (CTB) to produce a more sensitive tracer that has a 
limited capacity to be taken up by fibres of passage (Gonatas et al., 1979; Trojanowski et al., 
1981; Wan et al., 1982). Compared with native HRP, CTB-HRP labels a greater number of 
neurons and more efficiently reveals the dendritic tree of labelled neurons (Wan et al., 1982). 
Both WGA-HRP and CTB-HRP are bi-directionally transported that can be a disadvantage 
when teasing out a difference between afferent and efferent fibres for example (Gonatas et al., 
1979; Chen and Aston-Jones, 1995; Lanciego and Wouterlood, 2011). Another limitation is 
that the uptake of both conjugates relies on the availability of receptors on neuronal 
membranes, which is not always the case with viral vectors (Geerling et al., 2006). While the 
use of WGA-HRP is still popular, many studies do not account for the bi-directional nature of 
the tracer; it is generally regarded as a retrograde tracer (Lanciego and Wouterlood, 2011). 
 The lectin, Phaseolus vulagris (PHA-L) is an anterograde tracer that is taken up 
exclusively at neuronal cell bodies and is transported towards axon terminals (Gerfen and 
Sawchenko, 1984). Uptake is receptor mediated so is subject to the same limitations as the 
HRP conjugates (Gerfen and Sawchenko, 1984). PHA-L detection results in detailed 
visualization of a neuron in its entirety. PHA-L is often combined with other tracers, such as 
the biotinylated dextran amines (BDA), which will be discussed individually below. The 
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combination of PHA-L and BDA allows the study of multiple circuits converging into one 
brain area (Lanciego and Wouterlood, 1994). Like HRP, PHA-L may be taken up by damaged 
fibres of passage when mechanically injected into the brain however uptake into fibres of 
passages occurs less frequently with delivery by iontophoresis (Lanciego and Wouterlood, 
2011). PHA-L has also been seen to travel retrogradely in some systems suggesting that the 
nature of PHA-L transportation is not absolute and should be further investigated (Raju and 
Smith, 2006). 
 BDA was introduced as a quality anterograde tracer by Veenman et al. (1992) and 
initially used to trace neurons in the somatosensory cortex of the rat (Veenman et al., 1992). 
The mechanism by which BDA is taken up by neurons is still unknown, however, it seems to 
be taken up by both cell bodies and neuronal dendrites (Reiner et al., 2000). BDA remains 
stable in the rodent brain up to 4 weeks post injection making it a popular choice for 
longer-term neuroanatomical tracing studies (Veenman et al., 1992). BDA fills neurons by 
forming a homogeneous label inside neurons, in a way resembling classical Golgi 
impregnation (Lanciego and Wouterlood, 2011). This homogenous staining holds along the 
fibres to the terminals and allows clear visualization of neurons in their entirety and precisely 
maps fibre tracts. BDA may be transported retrogradely, the lower 3 kDa molecular weight 
BDA molecule is readily transported retrogradely and primarily used as a retrograde tracer, 
however, the more commonly used 10 kDa, infrequently travels retrogradely (Reiner et al., 
2000). Although, labelling of the 10 kDa tracer in areas retrograde to the site is limited, this 
labelling could lead to false interpretation of anterograde labelling, and the same rings true for 
the 3 kDa molecule, which may label anterograde pathways (Reiner et al., 2000) Therefore, 
care should be taken in interpreting the results of pathway tracing using BDA. Fibres of 
passage infrequently take up BDA, again leading to unspecific labelling and false results. 
Despite this, BDA is an extremely versatile tracer that efficiently labels neurons in sections of 
a range of section thicknesses and can be easily paired with other tracers to label more than 
one population of neurons (Lanciego and Wouterlood, 2011). Its versatility makes BDA a 
popular choice for anterograde tracing studies.  
 Although these tracers can effectively label the entirety of neurons, in either 
retrograde or anterograde directions, they all come with their limitations; uptake by all cells in 
the area of injection, uptake in fibres of passage, unintentional bi-directional labelling or 
relying on the membrane components of a neuron for uptake. HRP, PHA-L and BDA are not 
as sensitive or specific as viral vectors and were therefore not used in this study.  
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1.3.2 Lenti and adeno-associated viral vectors 
 The properties of a virus that enable it to insert its genetic information into healthy 
host mean it can also be exploited as a neuronal tracer. Of course this requires removal of the 
genetic components that make the virus harmful, and taking advantage of the traits that allow 
a virus to enter neurons, begin replicating and act as a self-amplifying signal within a neuron 
(Ugolini, 2010). A virus’s ability to cross synapses can be especially important when studying 
the connective patterns of neural circuits (Lanciego and Wouterlood, 2011). Viral vectors act 
as a delivery medium for the expression of a chosen reporter gene, which is driven by a 
specific promoter gene (Sizemore et al., 2016). The use of viral vectors can still be dangerous 
due to nature of the virus within the host cell and the slim chance of infection, therefore, they 
must be handled carefully under strict biosafety protocols.  
 Since the early 1980s researchers harnessed aspects of the human immunodeficiency 
virus (HIV) and developed recombinant viral vectors that have become appropriate for use in 
neuroscience research (Parr-Brownlie et al., 2015). Lentiviruses enter a host cell through the 
intact nuclear envelope, where the viral RNA is reverse transcribed into deoxyribonucleic 
acid (DNA) before it is integrated into the host genome. Host cells can be dividing or 
non-dividing cells (Naldini, 1998), making lentiviral infection suitable for the typically 
non-dividing neural cells targeted in tracing studies. Recombinant lentiviral vectors contain 
long terminal repeats required for replication and integration at either end of a packaging 
signal and an exogenous promoter that can be used to express a cell-type specific promoter to 
target a specific population of neuron (Dull et al., 1998), such as the 
calcium/calmodulin-dependent protein kinase II alpha (CaMKIIα) promoter to specifically 
target glutamatergic neurons (Parr-Brownlie et al., 2015). Having this level of labelling 
specificity allows a particular neuronal phenotype to be distinguished from others in the brain 
(Figure 1.5). Viral vectors diffuse smaller distances than non-viral tracers, such as HRP, 
PHA-L and BDA, permitting the transduction and tracing in a smaller and more controlled 
area of the brain (Lerchner et al., 2014). Large populations of neurons can still be targeted by 
injecting larger volumes of virus, or with multiple injections (Parr-Brownlie et al., 2015). 
 Producing viral vectors with added glycoprotein envelopes from a different virus 
strain, a process called pseudotyping, affords the ability to modify the site of lentiviral vector 
uptake (Indraccolo et al., 1998). Specific targeting of uptake can begin to be exploited, 
depending on a study’s objectives and the physical damage resulting from the injection 
procedure can be avoided. For example, if the aim was to look at the projections of a specific 
population of cells, vesicular stomatitis virus glycoprotein (VSVg) pseudotyped vectors 
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(Finkelshtein et al., 2013), can be injected into the vicinity of the cell bodies, and will 
anterogradely label the entirety of the neuron. In this scenario, the physical damage artefact 
caused by the injection at the cell bodies does not interfere with the results obtained at the 
projection sites (Parr-Brownlie et al., 2015). It is also possible to retrogradely label neurons 
with a lentiviral vector pseudotyped with the rabies glycoprotein (Schoderboeck et al., 2015). 
 Another option for viral vector tracing is the adeno-associated virus (AAV). AAVs are 
associated with high levels of expression and a larger site of diffusion around the injection 
site when compared to lentivirus (Packer et al., 2013). In some cases this can be more 
beneficial than the lentiviral construct, however not always, especially when delicate spatial 
specificity is required to trace a population of neurons in a small nucleus. The higher levels of 
AAV transduction may also lead to axonal malformations that could compromise tracing 
results (Miyashita et al., 2013), and AAVs are subject to inflammatory and immune responses 
to a greater extent than lentivirus  (Abordo-Adesida et al., 2005; Parr-Brownlie et al., 2015). 
 The evolution of viral vectors as anatomical tracers has been paramount to redefining 
the circuitry of the brain. The specificity that can be achieved at a sub-population level 
outmatches traditional tracing methods. Neural phenotypes can be targeted utilizing the 
expression of particular subcellular components, making it an ideal technique to investigate 
the specific phenotype of neurons in the rRTN.  
 
 
Figure 1.5. An example of the specificity afforded by the injection of lentiviral vectors 
into an area of the brain. In this case, the reporter fluorophores mCherry and green 
fluorescent protein (GFP) enable the dual labelling of glutamatergic neurons, promoted by 
CaMKIIα expression, and GABAergic neurons, promoted by GAD67 expression. 
(Adapted from Parr-Brownlie et al., 2015). 
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1.4 Rationale, aims and hypotheses  
 Presently, not a lot is known about how the RTN acts to modulate motor information 
between the motor thalamus and cortex. Converging inputs from the basal ganglia, motor 
cortex and motor thalamus to the rostral portion of the RTN suggest that it has a key role in 
the integration of messages relating to movement execution. Movement disorders, such as 
PD, have been extensively studied for decades, and although current treatments for PD can 
alleviate symptoms, the complete aetiology of the disease needs to be clarified. Due to the 
fact that the RTN receives inputs from basal ganglia nuclei, pathological changes occurring in 
the brain associated with PD may be associated with changes in the RTN. 
 Recently, electrophysiological data from our lab indicated that the RTN might contain 
at least 2 populations of neurons; a distinctive GABAergic population but also an undefined, 
non-GABAergic population. This second non-GABAergic population had a broad 
extracellular action potential width and some preliminary immunolabelling indicated that 
some RTN cells express markers such as the excitatory amino acid transporter EAAC-1, 
indicative of a glutamatergic phenotype. In light of this finding, I aimed to explore the 
phenotype of neurons in the RTN, often defined as being exclusively GABAergic, by utilizing 
dual immunohistochemistry to label multiple neuron-phenotype specific antigens. The small 
novel population of neurons were stained for CaMKIIα; a selective marker for glutamatergic 
neurons in the thalamus (Benson et al., 1991). Lentiviral vector technology was employed to 
selectively label this glutamatergic population of neurons to confirm the existence of these 
neurons in the rRTN and trace them to their potential synaptic targets. Due to the involvement 
that rRTN has with motor pathways, I examined the effect of dopaminergic lesions on the 
number and morphology of neurons in rRTN. 
 The project had the following hypotheses. As the literature suggest, the vast majority 
of neurons in rRTN would be GABAergic in phenotype, however, a small minor population 
of glutamatergic neurons would exist within the rRTN. Potential targets for this glutamatergic 
population may include other rRTN neurons, the motor thalamus, the globus pallidus or the 
striatum. Finally, in the 6-OHDA model of PD, no differences would exist in the number or 
morphology of neurons in the rRTN despite changes to the electrophysiology of these neurons 








 The rRTN regulates activity in the thalamus and has a vast array of inputs from a 
number of regions of the brain, including many that are involved in movement. The literature 
often states that the rRTN is exclusively GABAergic, however, recent evidence suggests that 
a non-GABAergic population of neurons exists within the nucleus. The pathophysiology of 
PD has been linked to many structures that the rRTN has connections with, however, little is 
known about the effect PD has on the rRTN. The following section will highlight the 
protocols I used to explore the phenotype of RTN neurons immunohistochemically, examined 
the effect of the chronic 6-OHDA model of PD on the neuronal populations within the rRTN 
and utilized lentiviral vector technology to selectively label and trace glutamatergic neurons 
within the rRTN.  
 The following procedures were approved by University of Otago Animal Ethics 
Committee (AEC 10/13; AEC 03/16) and conform to their guidelines. Throughout the study 
every effort was made to reduce the number of animals used. 
2.1 Animals 
 Twenty-six adult male Wistar rats (Hercus Taieri Resource Unit, University of Otago) 
were housed at 22°C in environmentally controlled conditions with a reversed 12 h light/dark 
cycle. Surgical procedures and behavioural testing were conducted during the animal’s dark 
cycle. Rats weighed between 290 g and 320 g at the time of the first surgery, and food and 
water were available ad libitum for the duration of the experiment. Rats were processed in 
two groups; one group underwent both 6-OHDA lesion, to induce a rat model of PD, and 
lentiviral injection surgeries and were used to determine neuronal phenotype and investigate 
neuronal tracing studies, and the second group underwent 6-OHDA lesions only and were 
used for stereology (see Figure 2.1). In both groups sham lesioned rats acted as a control 
group. 
2.2 Rat model of Parkinson’s disease 
 To investigate the effects that the neurodegenerative PD has on rRTN neuronal 
populations, the chronic 6-OHDA rat model of PD was used. The reproducibility, high rate of 
success and vast experience this lab has with this model (Parr-Brownlie et al., 2007, 2009; 
Walters et al., 2007; Avila et al., 2010; Bosch-Bouju et al., 2014), it was deemed the most 
appropriate choice from the models listed in Section 1.2.2. Standard behavioural tests and 
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immunohistochemistry for tyrosine hydroxylase (TH) have been employed to assess the 
extent of the lesion and ensure the success of the model. 
2.2.1 6-OHDA and sham lesions surgery 
 Unilateral lesions of the MFB were conducted in the left hemisphere of 28 rats. 
Roseanna Smither, a senior member of the lab, carried out 6-OHDA lesions and 5 of the 11 
sham lesions in animals. I did the sham lesions in 6 rats. Rats were deeply anaesthetised with 
a subcutaneous (s.c.) injection of a cocktail of ketamine (75 mg/kg; Parnell Technologies, 
NZ), domitor (0.5 mg/kg; Pfizer Animal Health, NZ) and atropine (0.06 mg/kg; Phoenix 
Pharm, NZ) (KDA). The state of unconsciousness was closely monitored throughout the 
procedure and if the level of anaesthesia was too light a top up dose of 0.1 ml KDA (s.c.) was 
administered. Rats were administered desipramine hydrocholride with an intraperitoneal (i.p.) 
injection (15 mg/kg; Sigma-Aldrich, USA), 30 minutes prior to infusion of the neurotoxin 
6-OHDA or vehicle to prevent uptake of 6-OHDA into noradrenergic neurons. Body 
temperature was maintained at 36-38 °C throughout the procedure and during the early stages 
of recovery by a heating pad. The area of incision was shaved and sterilized using three 
washes of betadine and ethanol. To provide local analgesia, lopaine (20 mg/mL, s.c.; Ethical 
Agents Ltd, NZ) was injected along the intended incision line and the antibiotic amphoprim 
(30 mg/kg s.c.; Virbac Animal Health, NZ) was administered to prophylactically prevent 
infection. Rats were mounted in a stereotaxic frame (Stoelting, USA), and eye ointment 
 
Figure 2.1. Outline of experimental groups with rat numbers for each stage of 
experimentation. 
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(Tricin; Jurox, Australia) was applied to prevent corneal dehydration. After ensuring rats were 
securely mounted, a midline sagittal incision exposed the cranial surface of the skull, the skin 
was retracted with small clips and subcutaneous tissue was carefully removed. The surface of 
the skull was cleaned with saline and dried to visualise bregma and lambda sutures. 
If bleeding persisted, the area was cauterised to ensure adequate visualisation of the sutures. 
A hole was drilled over the stereotaxic coordinates above the left medial forebrain bundle at 
+4.4 mm anteroposterior (AP) and -1.2 mm lateral (ML) from the lambda skull suture in the 
flat skull position. Bone chips were removed from the hole using fine forceps and the dura 
was reflected. The cannula was lowered 8.3 mm into the brain from the skull surface (DV). In 
lesioned animals, a solution of 6 µg of 6-OHDA (Sigma-Aldrich) in 3 µl of 0.9% saline 
containing 0.05% ascorbic acid was infused at a rate of 1 µL/min for three minutes. Control 
rats were sham lesioned with the same volume of vehicle solution that contained 0.9% saline 
and 0.05% ascorbic acid. After the infusion, the cannula remained in place for 5 min to 
prevent diffusion of 6-OHDA along the injection track. At the end of the procedure, the 
cannula was slowly withdrawn, the incision site was sutured and rats were administered 
carprofen (5 mg/kg s.c.; Norbrook, NZ) for long acting analgesic relief. To reverse the effects 
of the anaesthetic, rats were administered antisedan (2.5 mg/kg s.c.; Pfizer) and 5 ml of saline 
was injected to ensure rats did not become dehydrated overnight while the effects of the 
anaesthetic were wearing off.  
 Rats were transferred to individual cages and post-operatively monitored twice daily 
for 1 week. For easy access, wet rat chow was put into the rat’s cage and extra treats were 
given to ensure a healthy weight was maintained. Animals that were lesioned with 6-OHDA 
often lost around 6% of their pre-surgery bodyweight and took a number of weeks to re-gain 
weight to pre-surgical levels due to the pathology of the model. If an animal lost more than 
15% of their body weight post-operatively, the University of Otago veterinarian was advised 
to help choose the appropriate course of action, however, there was no instance where this 
occurred. In some cases, 24-48 h following surgery the suture had re-opened due to the rat 
scratching at it. In these instances a senior member of the lab assessed the animal, and the 
University of Otago veterinarian was informed of the situation. All cases resulted in the rat 
being re-sutured under the influence of the KDA anaesthetic following guidance and advice 
from senior members of the lab and close post-operative monitoring until the wound had fully 
healed.   
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2.2.2 Behavioural tests 
 To assess the extent of the dopaminergic lesion, rats were subjected to the behavioural 
motor tasks of step and cylinder testing at 5 to 7 days post-operatively (Olsson et al., 1995; 
Schallert et al., 2000). The forepaw contralateral to the hemisphere of 6-OHDA lesions was 
expected to have significantly impaired motor performance compared with the ipsilateral 
forepaw, whereas, no significant differences in step and cylinder test performance were 
expected for sham lesioned animals (Parr-Brownlie et al., 2007, 2009; Walters et al., 2007; 
Avila et al., 2010; Bosch-Bouju et al., 2014). From this point on, the contralateral forepaw 
will be referred to as the affected paw while the ipsilateral forepaw will be called the 
unaffected paw. Rats were considered to have had a successful lesion if the number of 
adjusting steps made with the affected forepaw was ≤ 10% of total steps and the forelimb was 
used for < 10 % of all touches made to the cylinder wall. If the behaviour of a lesion animal 
did not meet the criteria, the rat was considered unlesioned and was removed from the study. 
Previous studies imply that impaired motor performance on these tests is associated with a 
95% reduction in dopaminergic neurons in the SNc of the lesioned hemisphere (Olsson et al., 
1995; Fleming et al., 2005; Tseng et al., 2005; Avila et al., 2010). 
 Step testing Rats forelimb stepping performance is measured using the step testing 
(Olsson et al., 1995). The rats were trained for 3 days before lesion surgery, to acclimatise the 
animal and this researcher to the restraint and movement involved in this task (Figure 2.2 A). 
A senior member of the lab helped with the test on post-operative day 7 to ensure accurate 
analysis of the extent of PD lesion. The hind limbs and the forepaw not being assessed were 
restrained and the rat was moved slowly sideways along a one-metre bench surface in the lab. 
The number of adjusting steps for movements to the left and right were counted for the both 
unaffected and affected forepaw individually. With each trial the unaffected forepaw was 
tested first followed by the affected forepaw. The test was repeated 3 times in the same 
sequence for both forepaws and the result averaged. In general, 6-OHDA lesioned animals 
were expected to make a minimal number of adjusting steps with the affected forepaw 
compared to the unaffected forepaw and sham lesioned animals. 
 Cylinder testing Asymmetric forelimb use was examined using the cylinder test 
(Schallert et al., 2000). Rats were individually placed in a Plexiglas® cylinder (20 cm 
diameter x 30 cm height) for 5 minutes and scored for weight bearing limb touches with the 
wall of the cylinder (see Figure 2.2 B). The cylinder was high enough so that the animals 
could not touch the top edge when rearing occurred. Each session was video recorded from 
underneath the apparatus and scoring was assessed offline. The number of times the animal 
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placed their left forepaw, right forepaw or both forepaws together to the wall to support their 
weight was scored as a touch. Generally, 6-OHDA lesioned animals rarely use the affected 
forepaw for weight-bearing touches, instead placing the unaffected paw or both paws against 
the wall. 
2.2.3 Tyrosine hydroxylase staining 
 To assess the extent of dopaminergic neuron loss in the SNc and the loss of 
dopaminergic terminals in the striatum, staining for TH was employed. TH is an enzyme 
involved in the synthesis of catecholamines. In particular, the enzyme catalyses the 
hydroxylation of L-tyrosine to the dopamine precursor L-DOPA (Molinoff and Axelrod, 
1971). TH can, therefore, be used as a biomarker of catecholamine neurons throughout the 
brain and more specifically dopaminergic neurons in the SNc and dopaminergic terminals in 
the striatum. To label TH in the SNc and striatum, rats were perfused and 40 µm sections 
were obtained at the end of the experiments as described below in Section 2.3.1 and detection 
of TH was carried out with fluorescent immunohistochemistry. For a more detailed 
explanation of the immunohistochemistry procedure and the purpose of each step, see Section 
2.3.2 and 2.3.4. Briefly, sections were first washed in a phosphate buffered saline (PBS) for 
3 x 10 min, followed by 2 x 20 min permeabilization in PBS with triton added (PBS-T) and a 
1 hour block in a 10% normal goat serum (NGS) solution diluted with PBS-T. Sections were 
then incubated in the primary antibody rabbit anti-TH (see Table 1 for dilution and supplier) 
diluted with a PBS-T solution containing 5% NGS at 4°C overnight. The following morning 
sections were washed for 3 x 10 min in PBS-T and incubated in the secondary antibody anti-
rabbit dyelight 488 (see Table 1) for 4 hours at room temperature. Finally sections were 




Figure 2.2. Example images of the behavioural tests conducted during this study. (A) An 
example of the restraint used to examine the performance of the unaffected paw of a lesioned 
animal during step testing. Image obtained from Olsson et al. (1995). (B) An animal conducting a 




mounted onto glass slides in 0.1 M PB. Tissue was then left to dry to slides for 40 min to 
ensure they adhered to the slide and then coverslipped with Vectashield mounting medium 
with the fluorescent nuclei stain 4’,6-diamidino-2-phenylindole (DAPI) incorporated (Vector, 
USA). 
2.3 Characterising cell phenotype and tracing 
 To characterize the phenotype of neurons in the rRTN, the antigens CaMKIIα and 
GAD67 that are present in glutamatergic and GABAergic neurons, respectively (Benson et 
al., 1991; Kaufman et al., 1991) were immunohistochemically labelled. 
Immunohistochemistry utilizes antibodies that bind to antigens of interest in the rRTN and 
allows visualizing the location of these antigens with labels that can be detected with a 
microscope. Presently, the peroxidase based chromogenic immunohistochemistry and 
fluorescent immunohistochemistry were used to label RTN neurons. The use of chromogen 
staining enabled stereological investigation into the numbers of neurons in rRTN, and 
provided a cheap and long lasting method to visualize the antigens. In some rats, a lentiviral 
vector, which was driven by a CaMKIIα promoter and contained a mCherry fluorophore 
reporter, was injected into the rRTN to selectively label glutamatergic neurons at the injection 
site. If the injection was contained within the nucleus, the lentiviral vector enabled the tracing 
of rRTN neurons to their synaptic targets. For these rats, fluorescent immunohistochemistry 
provided confirmation of the location of CaMKIIα and GAD67 antigens at a much higher 
resolution as well as revealing the location of the mCherry fluorophore following lentiviral 
vector injections. 
2.3.1 Perfusions and processing 
 Two weeks following 6-OHDA or sham lesion surgery or 6 weeks following lentiviral 
surgery, rats were deeply anaesthetised with sodium pentobarbitone (100 mg/kg i.p; Provent, 
NZ). Rats were transcardially perfused with 10% sucrose solution followed by 4% 
paraformaldehyde (PFA) solution. Following fixation, brains were carefully removed and 
placed into a 4% PFA solution at 4 °C overnight. Brains were then transferred to a solution of 
30% sucrose to cryoprotect the tissue and stored at 4 °C for 2 days. Tissue was sliced into 
40 µm thick coronal sections on a freezing microtome and stored for up to 14 days in a 
24 well plate containing PBS at 4 °C until used for immunohistochemistry. For longer-term 
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storage, tissue was transferred to cryoprotectant containing 0.04 M Tris-buffered saline, 30% 
ethylene glycerol and 30% glycerol, sealed and stored at -20 °C. 
 2.3.2 Chromogen based immunohistochemistry 
 To ensure that the best possible staining was achieved, a series of different 
immunohistochemical techniques that were learned through guidance, literature research and 
experience were trialled. A number of antibodies were also trialled to select the appropriate 
marker for GABAergic and glutamatergic neurons.  For each antibody, a dilution series was 
completed to determine the ideal antibody concentration. Antibodies against a vesicular 
glutamate transporter (VGLUT-2; Synaptic Systems, Germany) were trialled however the 
resulting signal from the stain was inadequate, therefore staining with this antibody was not 
progressed any further. Antibodies for the markers used, GAD-67 and CaMKIIα that were 
raised in other species such as the chicken were initially trialled, however, these had more 
background staining than the mouse antibodies presented in the thesis. Techniques that I 
added to achieve the best antigen signal with the lowest background noise included 
peroxidase blocking, bovine serum albumin (BSA) combined with NGS blocking, and antigen 
retrieval, which are described and explained in the final protocol below. For full information 
on the antibodies and stains used including dilutions, host species and supplier, see Table 2.1. 
 Single chromogen staining For single chromogen immunohistochemistry sections 
were subjected to the following protocol. Firstly, tissue was washed for 2 x 5 min in PBS. 
Washing the tissue in PBS helps to produce the optimal environment for antibodies to bind to 
its antigens. At each washing step throughout the procedure, excess antibody, loosely bound 
non-specific antibodies and other debris are removed from the tissue to enable efficient and 
specific binding of the primary antibody. Due to the presence of endogenous peroxidases 
within some cells that may interfere with the HRP-conjugated antibody binding near the end 
of this protocol, which would cause non-specific background staining, tissue was pre-treated 
in a 0.3% hydrogen peroxide solution (H2O2) diluted with PBS for 10 min. Tissue was then 
washed in PBS for 2 x 5 min. To permeate the cell membrane and ensure access to antigens 
that exist within the cell, tissue was incubated in PBS-T, which contains the detergent Triton 
(Sigma-Aldrich, USA) at 2% for 2 x 20 min. Sections were then incubated in a blocking 
solution containing 10% NGS and 1% BSA diluted with PBS-T. NGS is employed as it is 
normal serum from the same species as the host of the secondary antibody (goat) and contains 
antibodies that will bind to non-specific reactive antigens that would increase background 
staining if they weren’t blocked. This allows the secondary antibody to exclusively bind only 
to the primary antibody. BSA is a protein buffer that will coat all proteins within the sample, 
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which means that it will compete with the primary antibody to bind to the specific antigen of 
interest (Wedege and Svenneby, 1986); therefore, it is used in small concentrations and in 
combination with NGS. After blocking, tissue is incubated at 4 °C overnight in primary 
antibody in a diluting buffer (DB) that contained 5% NGS and PBS-T (see Table 2.1 for  
antibody dilutions). The primary antibody was specific for the antigen that was being labelled. 
Specifically for GABAergic and glutamatergic neurons, mouse anti-GAD67 and mouse anti-
CaMKIIα antibodies were used. The following day, sections were again permeabilized in 
PBS-T for 2 x 10 min and washed for 3 x 5 min in PBS before incubation in DB containing 
the secondary antibody (see Table 2.1) for 2 hours at room temperature. The secondary 
antibody targets and specifically binds to the antibody. The secondary antibody is also 
conjugated to enzyme horseradish peroxidase that catalyses the reaction between H2O2 and a 
chromogen subsequently producing the signal that allows the antigen of interest to be 
visualized (see Figure 2.3).  Following the secondary antibody incubation, sections underwent 
3 x 5 min washes in PBS followed by the application of the 3’3-diaminobenzidine (DAB) 
substrate kit (Vector) according to manufacturers instructions. The kit contained the DAB 
chromogen, a diluting buffer and hydrogen peroxide that were combined and then added to 
the sections for 2 – 3 min, resulting in a brown reaction product. Finally sections were washed 
Table 2.1 List of antibodies and peroxidase substrates  
  Antibody Dilution Host Supplier 
Single chromogen staining 
Primary antibodies Anti-GAD67 1/10000 Mouse Merck Millipore, USA 
Secondary antibodies HRP conjugated Anti-mouse 1/800 Goat Invitrogen, USA 
 
Double chromogen staining 
Primary antibodies 
Anti-CaMKIIα 1/500 Mouse Merck Millipore 
Anti-GAD67 1/10000 Mouse Merck Millipore 
Secondary antibodies HRP conjugated Anti-mouse 1/500 Goat Invitrogen 
 
Fluorescent staining         
Primary antibodies 
Anti-CaMKIIα 1/300 Mouse Merck Millipore 
Anti-GAD67 1/1000 Mouse Merck Millipore 
Anti-RFP (5F8) 1/1000 Rat Chromotek, Germany 
Anti-TH 1/300 Rabbit Merck Millipore 
Secondary antibodies 
Anti-mouse Alexafluor 488 1/500 Goat Life-Technologies, USA 
Anti-rabbit Dyelight 488 1/1000 Goat Vector, USA 
Anti-rat Alexafluor 594 1/500 Goat Invitrogen 
 
  HRP substrates Reaction product colour Heat resistant Supplier 
DAB substrate kit Brown Yes Vector 
Vector SG substrate kit Blue-grey No Vector 
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in PBS for 2 x 5 min and 0.1 M PB for 10 min before being mounted onto glass slides and left 
to dry for 48 hours. 
 Heat-induced antigen retrieval The use of aldehyde fixatives during the perfusion 
process (see Section 2.3.2) may result in cross-linking of protein amino acid residues by 
methylene bridges. These protein cross-links can block the antigen sites and reduce the 
sensitivity of antibody binding and, therefore, reduce the staining (D’Amico et al., 2009). 
Applying heat to these sections removes these protein cross-links and allows access antigen 
binding sites (D’Amico et al., 2009). When required, sections underwent heat-induced antigen 
retrieval (HIAR). The particular CaMKIIα antibody clone used in the present experiment is 
known to be susceptible to blockage by protein cross-links and sections underwent HIAR 
only when this antibody was used. The general protocol for HIAR was as follows. Sections 
were washed for 2 x 5 min in PBS and then placed in 10 mM sodium citrate buffer (pH 6.0). 
Sections in citrate buffer were then placed in a steamer (George Foreman, ‘Food Steamer’, 
model: GF3TSBLK) for 13 min, then set aside for 2 min and transferred to PBS to carry on 
with the immunohistochemical protocol. 
 Dehydrate and clear After tissue had been left to dry so that they were sufficiently 
adhered onto glass slides, they were put through a general dehydration and clearing protocol. 
Clearing the tissue allows better visualization of the staining and using the mounting medium 
before applying a coverslip increases the longevity of staining. However, the clearing agent 
and the mountant used were not miscible with water, therefore, dehydration is required to 
remove water from the tissue. The chromogens used in this study, DAB and Vector SG, were 
both alcohol insoluble, therefore ethanol (EtOH) was used in increasing dilutions to dehydrate 
tissue. To dehydrate tissue slides were put in distilled H2O for 1 min, 50% EtOH for 1 min, 
70% EtOH for 5 min, 2 x 95% EtOH for 2 min, and 100% EtOH for 1 min and to clear the 
tissue, slides were put in xylene for 8 min. Finally a coverslip was applied with the mounting 
medium, DPX (Sigma-Aldrich).  
 Double chromogen staining The primary antibodies used for double 
immunohistochemistry were both raised in the mouse species and staining was completed 
over 4 consecutive days with each primary antibody added and visualized sequentially. The 
order that the antibodies were visualised was important for achieving the best signal to noise 
ratio. It was recommended by the manufacturer that tissue undergo HIAR before the 
CaMKIIα antibody was applied. After a series of trials it was determined that visualization of 
the CaMKIIα antibody was best with the chromogen vector SG (Vector). The HIAR step was 
best placed between the rounds of sequential staining (Lan et al., 1995), so CaMKIIα staining 
was completed during the second sequence. The chromogen DAB is heat-resistant so was not 
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affected by the HIAR step and used first to visualise the antibody GAD67. DAB is a robust 
chromogenic dye and may shield other antigens of interest that are in close proximity (van der 
Loos, 2007), therefore, extra washing steps were added to ensure that excess chromogen was 
removed from the tissue to prevent this DAB sheltering. Furthermore, the HIAR step 
inactivates peroxidase enzymes, therefore, preventing further DAB colour development.  
 For double chromogen immunohistochemistry tissue underwent the following general 
protocol, and see Figure 2.3 for a simple schematic of the double immunohistochemistry 
procedure. Sections were first washed for 2 x 5 min in PBS followed by a 10 min peroxidase 
block in a 0.3% H2O2 diluted with PBS. Sections were then washed for 3 x 5 min in PBS, and 
permeabilized for 2 x 20 min in PBS-T, before going through a 1 hour block in a solution 
containing 10% NGS, 1% BSA and PBS-T at room temperature. Following blockade, 
sections were incubated in the first primary antibody, mouse anti-GAD67 diluted in DB (see 
Table 2.1 for antibody dilutions) overnight at 4 °C. The second day consisted of 2 x 10 min 
washes in PBS-T and 3 x 5 min washes in PBS before application of the secondary antibody, 
anti-mouse conjugated with HRP in DB for 4 hours at room temperature. After secondary 
antibody incubation, sections were washed for 3 x 5 min in PBS and application of the DAB 
substrate kit (Vector) according to manufacturers instructions, which produced a brown 
A 
Figure 2.3. A series of schematic diagrams that briefly describe double 
immunohistochemistry. The first primary antibody that is specific to an antigen binds (1), is 
tagged by the secondary antibody (2) and revealed with a chromogen (3). The second primary 
antibody is then added and specifically binds to a different antigen in another cell (4). This 
antibody is then revealed with a different coloured chromogen (5,6). 
1 2 3 
4 5 6 












colour, before 4 x 5 min washes in PBS. The next day tissue underwent HIAR carried out as 
stated above, followed by 2 x 5 min washes in PBS, a 1 hour block in 10% NGS and 
incubation in the second primary antibody, mouse anti-CaMKIIα diluted with DB (Table 2.1), 
overnight at 4 °C. The following day sections were washed in PBS for 3 x 5 min and the 
secondary antibody, anti-mouse conjugated with HRP in DB was applied for 4 hours at room 
temperature. Sections were washed again in PBS for 3 x 5 min and put through a chromogen 
reaction with the Vector SG substrate kit (Vector), yielding a blue colour. Finally sections 
were washed in PBS for 2 x 5 min, 0.1 M PB for 1 x 10 min and mounted onto glass slides. 
The procedure outlined above to dehydrate and clear tissue was then carried out.  
 Controls The use of proper immunohistochemical controls was important for this 
study to ensure that staining was correctly interpreted and not falsely labelling other antigens, 
and to make sure that the staining was reproducible. To ensure that the primary antibodies 
were staining the antigens CaMKIIα and GAD67, tissue that had areas of the brain that have 
been previously shown to include these antigens in abundance were included in the staining 
procedures. The cortex and the hippocampus are known to express CaMKIIα (Colbran, 1992; 
Liu and Murray, 2012; Wang et al., 2013). Specifically in layers II, III, V and VI of the cortex 
and the pyramidal cell layer of region CA1 of the hippocampus (Colbran, 1992; Liu and 
Murray, 2012; Wang et al., 2013). Although the RTN itself is abundant in GAD67 staining, it 
could not be used as a control because it was the region of interest in this study; therefore the 
granule cell layer of the dentate gyrus was used. GAD67 and CaMKIIα are both present in the 
granule cell layer of the CA1 region of the hippocampus, however, do not colocalize in cells 
and form two distinct populations (Liu and Murray, 2012; Xiong et al., 2012; Wang et al., 
2013). Therefore, sections were taken through the cortex and CA1 region of the hippocampus 
to use as positive controls for CaMKIIα and GAD67 antibody staining, respectively. These 
positive control sections underwent the same protocol for single chromogen 
immunohistochemistry. DAB is known to have a sheltering effect on the signal of the second 
primary antibody in dual-labelling studies (van der Loos, 2007), therefore, the CA1 region of 
the hippocampus also acted as a control to ensure that complete chromogen separation had 
occurred. To test the non-specific binding of the secondary antibodies, sections taken from the 
rRTN were put through the staining procedures, however, the primary antibody was omitted 
from the dilution buffer. For double chromogen immunohistochemistry, 3 negative controls 
for non-specific secondary antibody staining were tested. Both primary antibodies were 
omitted in the same section, and then each primary antibody was omitted while the other 
remained in the protocol. In each case, the protocol remained the same except primary 
antibody was replaced with DB.   
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2.3.3 Lentivirus surgeries 
 A lentiviral vector was injected into the rRTN of 15 animals by Roseanna Smither to 
selectively label glutamatergic neurons (Figure 2.4). The coordinates for the rRTN were based 
on previous reports in the literature (Mihaly et al., 1998; Delfs et al., 1996), and from the rat 
atlas (Paxinos and Watson, 2009). The lentiviral construct, pLenti.CaMKIIα.mCherry was 
packaged into a third-generation lentiviral vector by the Brain Research NZ (BRNZ) Viral 
Vector and Optogenetics platform. The vector was pseudotyped with VSVg glycoprotein 
(Linterman et al., 2011), to ensure that the viral vector was anterogradely transported 
throughout the whole neuron and that synaptic terminals at the targets of these neurons could 
be traced with the expression of the mCherry reporter fluorophore. Approval for the use of 
recombinant lentiviral vectors was obtained from the Environmental Protection Authority 
(EPA) New Zealand (GMD003091). The CaMKIIα promoter sequence ensures glutamatergic 
neurons selectively express the viral vector (Parr-Brownlie et al., 2015), and the mCherrry 
reporter allowed the post-mortem analysis of the accuracy of viral vector transduction.  
 The lentiviral injection procedure closely resembled the unilateral lesion protocol 
outlined above with the following exceptions. Six rats received three injections of 100 nL 
(300 nL total volume) of lentiviral vector into rRTN. However, due to widespread 
transduction of the viral vector out of the rRTN, this was reduced to two injections of 100 nL 
(200 nL total volume) in the last 10 animals. Injections were made using a Hamilton 
microsyringe (World Precision Instruments Inc., USA) centred on the stereotaxic coordinates 
corresponding to the rRTN relative to bregma (-1.4 – -1.45 AP, +2.0 ML, -5.9 DV). The 
lentiviral construct was infused at a rate of 100 nL/min and the syringe remained in place for 
10 min to prevent diffusion of the lentivirus along the injection track as the syringe was 
withdrawn. Animals were housed in isolation cages for at least 72 hours during the period 
they were considered infectious, before being re-housed together in conventional cages for a 






   
Figure 2.4. Schematic of the lentiviral construct and the target injection site in rRTN. 
n = rRTN 




2.3.4 Fluorescent immunohistochemistry 
 Fluorescent immunohistochemistry works in much the same way as chromogen 
immunohistochemistry, with primary antibodies binding to the antigens of interest and 
secondary antibodies binding to the primary. The steps that ensure the best possible 
visualization of the signal are similar to that of chromogen immunohistochemistry and have 
been explained in detail in Section 2.3.2. Rather than using peroxidase enzymes and a 
substrate reaction to visualize the product, the antigens GAD67 and CaMKIIα were labelled 
with secondary antibodies that were conjugated to fluorophores (see Table 2.1). The 
fluorescent stain DAPI, which binds to DNA rich regions (Kapuscinski, 1995), was used to 
visualise the nuclei of neurons and was incorporated in the medium used to mount sections to 
the slides (Fluoroshield; Abcam, UK or Vectashield; Vector). These fluorophores emit a 
detectable signal when activated by a specific wavelength of light. The fluorescent signal in 
this study was, green, red or blue. Immunofluorescence enables the use of confocal 
microscopy rather than the light microscopy permissible with chromogenic 
immunohistochemistry. Confocal microscopy can generate an image of much higher optical 
resolution than that of light microscopy by eliminating out-of-focus light, which causes some 
background noise in images from light microscopy.  
 Single fluorescent staining To visualize neurons in rRTN that contain GAD67 or 
CaMKIIα, 40 µm sections were put through the following protocol for fluorescent 
immunohistochemistry. Solutions used in the present protocol were the same as those listed in 
Section 2.3.2 unless otherwise stated. All steps in this protocol were completed with the lights 
off and the blinds closed to ensure fluorescent signal was not bleached by external light. First, 
sections were washed in PBS for 3 x 10 min followed by permeabilization in PBS-T for 
2 x 20 min. Sections were incubated in a 10% NGS blocking solution that was diluted with 
PBS-T for 1 hour, and then sections were transferred to wells containing primary antibody 
diluted in DB (see Table 2.1) overnight at 4 °C. The primary antibodies that were used were 
either mouse anti-GAD67 or mouse anti-ααα Following primary antibody incubation 
overnight, sections were washed for 2 x 20 min in PBS-T and incubated for 4 hours in 
secondary antibody diluted in DB (Table 2.1), at room temperature. The secondary antibodies 
that were used were either goat anti-mouse Alexa Fluor 488 or goat anti-mouse Alexa Fluor 
594. Sections were then washed in PBS for 2 x 10 min and finally 0.1 M PB for 10 min 
before being mounted onto glass slides in 0.1 M PB. After allowing sections to adhere to the 
slide for 30-40 min a coverslip was applied with Fluoroshield mounting medium with DAPI 
incorporated (Abcam).  
 
 52 
 Double fluorescent staining To visualize the location of GAD67 positive neurons and 
virally transduced neurons expressing the mCherry fluorophore in the same section, tissue 
around the lentivirus injection site underwent double fluorescent immunohistochemistry. This 
protocol was also used to confirm GAD67 and CaMKIIα were not co-localizing in neurons 
and that two distinct populations of neurons existed in the rRTN. The protocol used follows 
the exact steps as those for single fluorescent staining listed above except for the following 
exceptions. Primary antibodies against GAD67 (mouse anti-GAD67) and the mCherry 
fluorophore (rat anti-RFP 5F8) were added simultaneously each diluted in DB (see Table 2.1). 
The secondary antibodies Alexa Fluor 488 goat anti-mouse and Alexa Fluor 594 goat anti-rat 
were diluted in DB and added simultaneously. At the end of the protocol, sections were 
mounted onto glass slides in 0.1 M PB, left to adhere for 40 min and a coverslip was applied 
with Vectashield mounting medium with DAPI incorporated (Vector). 
2.4 Imaging tissue 
 All tissue was imaged with microscopes provided by the Otago Centre for Confocal 
Microscopy. Brightfield light microscopy and confocal fluorescent microscopy were both 
used during this study. Brightfield microscopy was employed to define the rRTN boundary, 
count neurons in the rRTN and image chromogen stained tissue, whereas confocal 
microscopy was used to investigate the cell phenotype of neurons within the rRTN as well as 
viral vector injections. Confocal microscopy offers a number of advantages over brightfield 
including the removal of out of focus objects that may obstruct the in focus fluorescent signal 
and the confocal microscope produces higher resolution, clearer images. Some disadvantages 
that were considered in the overall project design were that confocal microscope is expensive 
and the processing of high-resolution images with the available software is especially 
time-consuming. 
2.4.1 Defining the boundary of rostral reticular thalamic nucleus 
 As outlined in Section 1.1.4, the RTN is functionally split into sectors along its rostral 
to caudal axis, however, these sectors have no definitive boundary line. Therefore, we felt it 
prudent to define the rostral portion of the RTN, which would be involved in motor 
processing, before conducting neuronal cell counts. Previous literature studying rRTN suggest 
that the motor portion lies just before the rostral pole of the nucleus, and is adjacent to 
structures such as the ventrolateral part of the anteroventral thalamic nucleus (AVVL) at the 
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rostral part of rRTN and VA/VL thalamic nucleus at the more caudal part of rRTN (Cicirata 
et al., 1990; Delfs et al., 1996; Picazo et al., 2009; Villalobos et al., 2016). For the current 
study, we defined the motor portion of the RTN as -1.2 mm to -1.6 mm relative to bregma 
with regards to the Paxinos and Watson (2009) atlas (Figure 2.5). 
2.4.2 Confocal microscopy 
 Sections of rRTN were examined on a microscope to determine the location of 
lentiviral transduction as well as to characterize the phenotype of neurons in the rRTN as 
described earlier. A confocal laser-scanning microscope (Nikon A1R MP, Japan), was used to 
assess lentiviral transduction and fluorescent immunohistochemistry using 4x (0.1 numerical 
aperture (NA)) Plan, and 40x (0.75 NA) Plan Fluor objective lenses. Lasers had excitation 
lines of 405 nm, 488 nm, and 561 nm to excite blue, green and red fluorophores respectively. 
Pictures were taken with Nikon Elements C (Version 4.13.01; Nikon, Japan), software 
running on a computer running Windows 7 (Microsoft, USA), that was connected to the 
microscope. ND2 files that held the imaging information from the NIS Elements C software 
were imported into FIJI, which is a distribution of the software ImageJ (Schindelin et al., 
2012; Schneider et al., 2012), and saved as a tagged image file (TIF) for greater compatibility. 
A 
Figure 2.5. Sections of the rRTN revealed with DAB staining of the GAD67 antibody.  
Each image represents a 40 µm section and approximately 8 sections defined the rostral 




Rt Rt Rt 
 
 54 
2.4.3 Brightfield light microscopy 
 Following chromogenic labelling of the rRTN, sections were viewed with a light 
microscope (Olympus BX61, Japan), using 4x (0.16 NA) UPlanSApo, 10x (0.4 NA) 
UPlanSApo and 40x (0.95 NA) UPlanSApo objective lenses. The microscope was attached to 
a computer running Mac OS X (Version 10.6.8; Apple, USA) with Volocity software 
(Version 5.2.0; Improvision, USA), installed to control a motor driven stage. Images were 
taken with a QImaging micropublisher (Diagnostic Instruments, Canada) camera that allowed 
precise image montaging of the rRTN. Montaged images were stitched together using 
AutoPano Pro software (Version 2.5.2; Kolor, France).  
 To estimate the volume of the rRTN and the number of GABAergic and glutamatergic 
neurons, Stereo Investigator software was used (Version 10.21.1; MBFbioscience, USA). The 
Windows 7 computer (Microsoft) was also connected to a light microscope (Olympus BX51) 
and the microscope stage was motor driven. The rRTN was delineated using a 4x (0.13 NA) 
UPlanFl N objective lens, while neurons were counted with a 40x (0.75 NA) UPlanFl N 
objective lens.  
2.5 Stereology 
 All tissue that was used for stereological cell counts was processed as a group together 
to ensure that conditions for tissue processing were the same.  
2.5.1 Cavalieri estimator  
To get an unbiased estimate of volume of the rRTN the Cavalieri estimator probe was used. 
The Cavalieri estimator probe applied systematic random sampling to every 2nd section 
throughout the RTN to get the volume of the rRTN in which the GABAergic and 
glutamatergic neurons were counted. To apply the Cavalieri estimator, a point grid was 
overlaid onto the rRTN with each point spaced equally across and down at 50 µm. The 
investigator then counts how many points were selected within the rRTN and an unbiased 
estimate of the volume of the region was calculated (Figure 2.6). 
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2.5.2 Optical Fractionator  
Due to the complex shape of the RTN, the Optical Fractionator probe was employed to 
estimate the total number of GABAergic and glutamatergic neurons in the rRTN. The Optical 
Fractionator probe employs the Optical Disector with the fractionator method to count cells in 
a 3-dimensional space. The disector method allows the estimation of the number of objects 
within a region without making assumptions based on size, shape or orientation. The 
fractionator allows the sampling of objects in a number of thick sections from a known 
fraction of tissue that allows systematic random sampling of objects in the X, Y and Z-axis 
(Keuker et al., 2001).  
 By counting a subset of the total number of neurons in every 2nd section of the rRTN 
it is possible to estimate the total population within the rRTN that can then be assessed 
statistically. Firstly the boundary of the rRTN was delineated using the contour drawing tool 
based on the RTN figure in the Paxinos and Watson (2009) atlas. The RTN is easily 
distinguishable due to the high GABAergic immunoreactivity of the region. Once the rRTN 
had been outlined the Stereo Investigator software applied a random sampling grid, of 10,000 
µm2, across the region and a counting frame was placed onto the section. The counting frame 
penetrated the volume of the tissue and the user focussed through the section and counted 
cells throughout the volume of the region. This counting frame allowed unbiased counting of 
cells in three dimensions using a set of rules that remained consistent across all sections of the 
animals that were investigated. The mounted thickness was measured for each section as well 
as at every 10th sampling point within the tissue. 
 Every 2nd section of the rRTN was analysed using the Optical Fractionator probe. 
Once the rRTN had been delineated, random systematic sampling was used to apply sampling 
 
Figure 2.6. An example frame depicting the Cavalieri estimator probe. Intersecting points 
on the grid within the region of interest are marked (green) and counted. Knowing the size of 
the grid (100 µm x 100 µm) it is possible to estimate the total volume of the region of interest. 
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points across the rRTN, up to 200 µm apart in the X and Y-axis directions so that a total of 30 
sampling points were applied in each section. The Optical Disector penetrated 12 µm into the 
z-axis of each section excluding 4 µm at the top and bottom to account for tissue damage due 
to sectioning and processing. At each sampling point a 10,000 µm2 counting frame was 
applied to the tissue within which GABAergic and glutamatergic neurons were counted. Due 
to some neurons crossing the counting frame, unbiased counting rules were applied to avoid 
the ‘edge-effect’ (Gunderson et al., 1987), which can cause the overestimation of neurons 
within the region. This required inclusion and exclusion borders of each of the edges of the 
counting frame (see Figure 2.7). Neurons intersecting the top and right borders of the 
counting frame were included in the count and those intersecting the bottom and left borders 
of the counting frame were excluded (Gunderson et al., 1987). This ensures that a neuron 
would only be counted once even when the counting frames were a minimal distance apart. 
To count each cell within the counting frame, different markers coded GABAergic and 
glutamatergic neurons. Each marker was placed at the top of a neuron if the neuron came into 
focus in the 12 µm distance of the z-axis and fell within the counting frame, or intersected the 
inclusion borders of the counting frame. They would not be marked if they were out of focus 
within the z-axis, or intersected the exclusion borders of the counting frame (Figure 2.7). 
 The total number of GABAergic and glutamatergic neurons was estimated in 
4 sections per animal using the Stereo Investigator software. This software automatically 
calculates the total number using the following formula:  
 
N = ΣQ– x t/h x 1/asf x 1/ssf 
 
Where ‘N’ = the estimated total population, ‘Q–’ = neurons counted, t = section mounted 
thickness, h = counting frame height, asf = area sampling fraction, ssf = section sampling 
fraction. The area sampling fraction is defined as the distance between counting frames in the 
x and y direction squared, divided by the counting frame area and the section sampling 
fraction is the section increment (i.e. 1 of every 2 sections or 1/2). 
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2.6 Morphometric analysis 
 The area of GAD67 staining around soma was determined using the measure and label 
function of ImageJ (Schindelin et al., 2012; Schneider et al., 2012). Firstly, sections were 
selected from each animal that contained the same volume of rRTN, which had been 
measured previously. Each section was photographed with an Olympus BX51 microscope, 
using a 20x (0.5 NA) UPlanFl N objective lens and subsequently stitched together in Adobe 
Photoshop CC (Version 2014.0.0, Adobe Systems incorporated, USA). Although not directly 
stained for, the nucleus of each neuron was easily identified as the relatively unstained area 
within GAD67 immuno-positive neurons (Figure 2.8 A). Somal area measurements were 
made on 20 clear neurons randomly selected per rat resulting in 80 and 100 values for sham 
and 6-OHDA lesioned groups. As illustrated by Figure 2.8 B, all neurons that had sufficient 
immunoreactivity around their soma were outlined with the ellipse tool in ImageJ (Derecki et 
al., 2012; Schneider et al., 2012; Amorin and Calisi, 2015). A small proportion of somata 
could not be clearly outlined due to out-of-focus blur, background staining or clusters of 
neurons, therefore, these were not included in analyses. The area of the outlined neuron was 
then measured with ImageJ (Schneider et al., 2012), and exported to an excel spreadsheet. To 
ensure a neuron was not outlined twice, a small mark was added to each a neuron following 
measurement. 
 
Figure 2.7. An example of the rules that were applied while counting neurons in the 
rRTN. Green arrows indicate neurons that would be included in the count, and red arrows 
indicated neurons that would be excluded.  
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2.7 Data analysis 
 All data were analyzed using the software package Prism (Version 7.0a, GraphPad 
Inc, USA). A Shapiro-Wilk normality test was used to test whether the sampled data were 
normally distributed. If the normality test was passed (p ≥ 0.05), it confirmed that data were 
normally distributed and a parametric test was used to determine statistical significance. 
However, p ≤ 0.05 indicated that the data were not normally distributed and non-parametric 
tests were used to compare differences between groups. The following variables were 
compared between sham and lesion treatment groups using unpaired, two-tailed students 
t-tests: the number of affected forelimb adjusting steps made by a rat, number of touches 
made against a cylinder wall with the affected forelimb, the total number of GABAergic 
neurons in the rRTN, the total number glutamatergic neurons in the rRTN and the total 
measured volume of rRTN. A Mann-Whitney test was computed to compare differences in 
the mean area of the soma of neurons in the rRTN between sham and 6-OHDA lesioned 
groups. To assess the relationship between the number of GABAergic neurons and 
behavioural performance, the Pearson Product Moment Correlation coefficient was calculated 
in Prism. Data are presented as the mean ± the standard deviation (SD). The value of 
probability that defined a significant difference between groups was set at p ≤ 0.05. 
Throughout the results section, the p value presented was computed with an unpaired, two-
tailed students t-test unless otherwise stated 
 
  
Figure 2.8. A representative figure showing GAD67 immunoreactivity alone and the 
same image with outlines of the soma of neurons that were measured. Scale bar = 100 µm 
(A) GAD67-positive neurons have a clear soma, where GAD67 staining (brown) is around the 
nucleus (clear). (B) The soma of neurons that were measured was outlined with a yellow 
ellipsoid. Examples that would not be counted due to out-of-focus blur, background staining 








 The present study aimed to define and characterise the phenotype of a novel 
population of neurons within the rRTN using general immunohistochemistry, stereology, 
morphometric analysis and lentiviral tracing technology. The effect of loss of midbrain 
dopamine neurons on neuronal numbers within the rRTN was also examined. To achieve this, 
28 rats were subject to either 6-OHDA or sham lesions to the MFB, which was followed with 
lentiviral injections into the rRTN in 15 rats. It was deduced that a small novel population of 
neurons that were positive for CaMKIIα immunostaining existed within the rRTN and were 
presumed to be glutamatergic in phenotype. Finally, it is proposed that a dopaminergic lesion 
causes a significant increase in the estimated number, and decrease in the size of GABAergic 
neurons in the rRTN, however does not change the volume or population of glutamatergic 
neurons.  
3.1 Model of Parkinson’s disease 
3.1.1 Behavioural tests 
 Behavioural assessment The extent of 6-OHDA lesions was tested behaviourally 
using the step test to assess the stepping ability of the affected forepaw relative to the 
unaffected forepaw and the cylinder test that examines forepaw preference for weight bearing 
touches against a cylinder wall (Figure 3.1 A and B).  
 Normality tests confirmed that step testing data for sham and 6-OHDA lesioned 
animals was normally distributed (Shapiro-Wilk test; p = 0.31 and p = 0.71, respectively). In 
sham lesioned animals, the adjusting steps made by the affected forepaw and the unaffected 
forepaws were approximately equal (Figure 3.1 A) and no significant difference was seen 
between the two. In addition, sham lesioned rats used the affected forepaw to bear weight 
against the cylinder wall for approximately a quarter of weight bearing touches 
(Figure 3.1 B), which is the same for weight bearing touches with the unaffected forelimb 
(23 ± 8%; data not shown) and they used both limbs simultaneously for approximately 50% 
of weight bearing touches (58 ± 17%; data not shown).  
 In comparison, 6-OHDA lesion animals displayed a reduced ability to take an 
adjusting step with the affected forepaw during the step test. With a successful 6-OHDA 
lesion, the adjusting steps taken with the affected forepaw were severely reduced compared to 
the adjusting steps taken with the unaffected forepaw. This led to a significant decrease in the 
adjusting steps taken with the affected forepaw compared against the affected forepaw of 
sham lesioned animals (Figure 3.1 A, p < 0.0001).  
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 Normality tests confirmed that cylinder test data was sampled from a normal 
distribution for both sham and 6-OHDA lesioned animals (Shapiro-Wilk test; p = 0.32 and 
p = 0.06, respectively). Animals with 6-OHDA lesions showed a strong paw preference to the 
unaffected forepaw for weight bearing touches to the cylinder wall. Successfully lesioned 
animals barely used the affected forepaw to bear weight, preferring to use either the 
unaffected forepaw (40 ± 20%) or both paws simultaneously (59 ± 15%; data not shown). As 
shown in Figure 3.1 B, the 6-OHDA lesioned animals showed a definitive paw preference to 
avoid weight bearing with the affected forepaw compared against the same forepaw of sham 
lesioned animals (p < 0.0001). 
3.1.2 Tyrosine hydroxylase staining 
  The effect of 6-OHDA lesions on dopaminergic neurons in rats was qualitatively 
assessed with TH immunohistochemical staining. Coronal sections, 40 µm thick, were 
obtained through the SNc and the striatum of sham and 6-OHDA lesioned animals and stained 
with an antibody against TH. Tissue that went through TH immunohistochemistry was from 
animals that had met the criteria for the behavioural assessments and indicated a successful 
lesion. 
 As shown in Figure 3.1 C, there is a distinct lack of TH immunostaining in the left 
SNc of 6-OHDA lesioned animals compared to the unaffected right SNc. This difference is 
not seen in sham lesioned animals indicating that dopamine neurons were lost in the SNc 
following 6-OHDA lesions. In the striatum, it is clear that the terminals of dopaminergic 
neurons have diminished in the left hemisphere of 6-OHDA lesioned animals compared with 
the right hemisphere, and sham lesioned animals exhibit no difference in staining. 
3.1.3 Summary of 6-OHDA induced dopaminergic lesions 
 Overall, 5 rats were excluded from the experiment due to unsuccessful 6-OHDA 
lesions, as they did not meet the behavioural criteria stated in methods Section 2.2. Those rats 
that did meet the criteria showed a reduced motor performance with the affected forepaw in 
the step test and a paw preference asymmetry that favoured the unaffected forepaw or both 
forepaws for weight bearing touches in the cylinder test when compared with sham lesioned 
animals. These results were confirmed with qualitative analysis of dopaminergic 
immunohistochemistry in the SNc and the striatum. There was reduced staining of the 
dopaminergic neurons in the ipsilateral SNc and the dopaminergic terminals of ipsilateral 





Figure 3.1. Behavioural and immunohistochemical assessment of 6-OHDA lesions in 
rats. (A) The adjusting steps made by the affected forelimb as a percentage of total adjusting 
steps in sham and lesioned rats. (B) Affected forelimb weight bearing touches against the 
cylinder wall expressed as a percentage of total touches in sham and lesioned rats. (C) 
Coronal sections of the SNc (left) and striatum (right) from example rats show cell 
immunoreactivity for tyrosine hydroxylase (TH) (green). TH immunostaining is similar 
between the injected (left) and uninjected (right) hemispheres in sham rats. In contrast, the 
lack of TH immunostaining in the left hemisphere of the SNc and striatum in rats who 
underwent 6-OHDA lesions illustrates that dopamine cells were lost in the ipsilateral 












































3.2 Characterizing neuronal phenotype and lentiviral vector labelling 
3.2.1 GABAergic population in the rostral reticular thalamic nucleus 
 The rRTN has primarily been characterized as a GABAergic nucleus. To confirm that 
the rRTN studied in the present experiment did indeed contain GABAergic neurons, tissue 
underwent immunohistochemistry for the GAD67 antibody and was visualized with a green 
fluorescent secondary antibody (Figure 3.2 A) or the chromogen DAB (Figure 3.2 B). 
GABAergic neurons were stained throughout the rRTN in the characteristic reticulated 
arrangement. GAD67 staining occurred mostly around cell coma and revealed both medium 





Figure 3.2. GABAergic immunohistochemistry in a representative section of rRTN. (A) 
Neurons in the rRTN positively labelled for GAD67 (green) and nuclei stained with DAPI 
(blue) showed examples of medium fusiform (a) or large fusiform (b) neuron shapes. Image 
obtained using a 40x objective lens, scale bars = 100 µm. Inset imaged with a 10x objective 
lens shows the rRTN labelled with GAD67 neurons. (B) Neurons positive for GAD67 
revealed with DAB in the rRTN. DAB staining was found around the perikarya and primary 
dendrites of neurons. Image obtained with a 10x objective lens, scale bar = 50 µm. (C) 
Schematic diagram representing the approximate location of rRTN in the presented images 
(Paxinos and Watson, 2009). Rt = rRTN, ic = internal capsule, AVVL = anteroventral 






3.2.2 Glutamatergic population in the rostral reticular thalamic nucleus 
 Previous electrophysiology research in this lab indicated that there was a novel 
subpopulation of neurons in rRTN, which had broad action potentials indicative of 
glutamatergic activity. To investigate this further, sections of rRTN were 
immunohistochemically stained using the antibody for CaMKIIα	and detected with either a 
red fluorescent secondary antibody or the Vector SG (blue) chromogen. CaMKIIα staining in 
rRTN confirmed the presence of a small population of glutamatergic neurons. Glutamatergic 
neurons were sparse in the rRTN and had small round perikarya (Figure 3.3 A and B). Most 
often, neurons positively stained for CaMKIIα were found in the medial aspect of rRTN 
(Figure 3.3 A). 
A 
Figure 3.3. Neurons in a representative section of rRTN showing positive staining for 
CaMKIIα. (A) A neuron in the rRTN that positively stained for CaMKIIα (red, arrowhead) 
and nuclei stained with DAPI (blue) has small round soma and suggests a glutamatergic 
phenotype exists within rRTN. Image obtained with a 40x objective lens. Inset obtained with 
a 10x objective lens shows the rRTN is relatively absent of staining, however, the white arrow 
indicates the same arrowhead as in (A), located in the medial aspect of the rRTN. Scale 
bars = 100 µm. (B) Single chromogenic staining reveals a neuron positive for the CaMKIIα 
antibody (black arrowhead) in the rRTN. Image obtained with a 40x objective lens. Scale 
bar = 50 µm (C) Schematic diagram representing the approximate location for rRTN of the 
presented images (Paxinos and Watson, 2009). Rt = rRTN, ic = internal capsule, 
AVVL = anteroventral thalamic nucleus, AM = anteromedial thalamic nucleus, 





3.2.3 Distinct population of neurons in the rostral reticular thalamic nucleus 
 Double chromogen staining To assess the extent of the glutamatergic population 
within rRTN, neurons were double-stained for GAD67 and CaMKIIα. A number of 
immunohistochemical trials were undertaken to ensure that the two chromogen-based stains 
were distinct and the best possible signal to noise ratio was achieved (Figure 3.4). The final 
result shows separation of the two chromogens, DAB and Vector SG, even at the close 
proximity of neurons (Figure 3.4 F) and the negative and positive controls that were 
processed alongside the regular staining procedures are represented in Figure 3.4 A-D. With 
the lack of background staining, negative controls suggest that the secondary antibody was 
binding to the primary antibody rather than non-specific binding sites and the chromogen was 
revealing the signal from the secondary antibody rather than endogenous peroxidase activity 
(Figure 3.4 A-C). Positive controls confirmed that the GAD67 and CaMKIIα antibodies were 
binding to the appropriate molecules in regions that are known to express these antigens 
(Figure 3.4 D and E). 
 
Figure 3.4. Example images illustrating the control tissue for double chromogen 
immunohistochemistry. In all images scale bar = 100 µm. (A) The removal of both primary 
antibodies reveals no background staining and a successful negative control. (B, C) Omission 
of the GAD67 (B) or CaMKIIα (C) primary antibody from the regular immunohistochemistry 
procedure reveals no obvious DAB (B) or vector SG (C) background staining. (D) Positive 
staining in the hippocampus verified the GAD67 primary antibody staining. (E) Positive 
staining in the cortex verified the CaMKIIα primary antibody staining. (F) An example of the 
separation of the brown (DAB) and blue (Vector SG) colours of chromogenic staining even 
with close proximity of neurons in the CA1 layer of the hippocampus.  
A B C 
D E F 
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 Following double staining for GAD67 and CaMKIIα, neurons in the rRTN were 
stereologically investigated using the Optical Fractionator probe in Stereo Investigator. 
Neurons that were positively stained for either marker were counted to get an estimate for the 
total population of neurons in rRTN. As shown in Figure 3.5 A, neurons positively marked 
for CaMKIIα, indicative of the novel glutamatergic population, made up a small percentage of 
the total population of neurons counted in rRTN. As stated in Section 2.5.2, every 2nd section 
of rRTN tissue was counted, therefore, the estimated total numbers stated below are ½ of all 
neurons in the rRTN. On average, sections contained 14 ± 2 neurons positively stained for 
CaMKIIα, whereas sections contained 561 ± 40 neurons that positively stained for GAD67. 
Two examples of individual glutamatergic neurons that were counted are illustrated in 
Figure 3.5 B1 and B2. No colocalization of both GAD67 and CaMKIIα in individual rRTN 
neurons was observed. Neurons that were positive for CaMKIIα staining appeared to have 
discrete overlying positive staining for GAD67 on their soma, indicative of passing dendrites 
or axons near the soma. 
 Lentiviral transduction of rRTN neurons To confirm the presence of a novel and 
distinct glutamatergic population of neurons, the lentiviral construct; 
pLenti-CaMKIIα-mCherrry, was injected into rRTN. Rats were left for 6 post-surgical weeks 
to allow for sufficient time for viral vector transduction of rRTN neurons. Rats were injected 
in small groups and the location of virus transduction was reviewed before injecting the next 
group. The mCherry fluorophore allowed for quick detection to ascertain the injection success 
of the lentivirus into rRTN. No injection was fully contained within rRTN (for example 
 
Figure 3.5. Two distinct populations of neurons exist within the rRTN. (A) The 
population of GABAergic and glutamatergic neurons in the rRTN as a percentage of total 
number of stereology corrected neurons. (B1, B2) Representative images illustrating two 
individual glutamatergic neurons (black arrow) amongst GABAergic neurons in the rRTN. 


































Figure 3.6 C), however the mCherry fluorophore can be seen in transduced neurons (Figure 
3.6 A). The presence of the lentivirus confirms that the glutamatergic marker CaMKIIα is 
present in rRTN and as seen in Figure 3.6 B, and it does not co-localize with GAD67 further 
confirming that a population of glutamatergic neurons exists within rRTN. Transduced 
neurons were small with round perikarya, took a multipolar shape and were found in the 
middle and medial aspects of rRTN (Figure 3.6). These neurons were found in a line that 
seemed to follow the injection path, and were interspersed with GABAergic neurons. 
 The lentiviral vector was pseudotyped with VSVg to ensure the vector was taken up at 
the soma and the fluorophore was transported along the axon of transduced neurons to its 
synaptic terminals. However, due to the inability to confine lentiviral injections within the 
rRTN, it was deemed futile to trace transduced glutamatergic thalamic neurons to their 
synaptic targets because of the possibility that projection neurons from non-rRTN structures 
had transduced by the virus e.g. VA/VL and AVVL thalamic nuclei. 
3.3 The effect of dopaminergic lesions on the rostral reticular thalamic nucleus 
 To assess the effect of 6-OHDA lesions on the number of neurons in rRTN, the 
Optical Fractionator probe in Stereo Investigator was used to count the neurons positively 
stained for the GABAergic marker GAD67 and glutamatergic marker CaMKIIα and 
compared in sham and 6-OHDA lesioned animals (Figure 3.7). The data obtained by 
stereological cell counts for GABAergic neuronal number were normally distributed in sham 
and 6-OHDA lesioned animal (Shapiro-Wilk test; p = 0.82 and p = 0.35, respectively). 
Glutamatergic cell count data were also normally distributed in sham and 6-OHDA lesioned 
animals (Shapiro-Wilk test; p = 0.25 and p = 0.23, respectively). 
 Before counting neurons in the rRTN, each section’s volume was measured using the 
Cavalieri estimator. To ensure the mounted thickness did not bias the tissue between groups, 
all processing was completed simultaneously. Due to the changing shape of the rRTN along 
its rostral to caudal axis, the volume of the rRTN in sham and 6-OHDA lesioned sections was 
variable (Figure 3.7 A). There was no difference found in the rRTN volume between sham 
and 6-OHDA lesioned animals suggesting that sections were taken from the similar aspects in 
both animal groups. Furthermore, although there was a small trend towards an increase in 
volume of the rRTN in the sections of 6-OHDA lesioned animals, this did not reach statistical 
significance (p = 0.46).  
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 The results from the parkinsonian lesion experiment suggest that 6-OHDA altered the 
number of neurons positive for GAD67 (Figure 3.7 B). The mean number of GABAergic 
neurons counted in the rRTN of 6-OHDA lesioned animals was significantly increased 
compared to sham lesioned control rats (p = 0.04).  
 Large and medium sized fusiform GABAergic cells appeared throughout the rRTN in 
sham animals. Neuron soma area measurements were normally distributed for the sham 
lesioned group (Shapiro-Wilk test; p = 0.0853) and 6-OHDA lesioned data were not normally 
distributed (Shapiro-Wilk test; p < 0.0001). As illustrated by Figure 3.7 C, fusiform cells that 
were positive for GAD67 staining in the rRTN had a smaller mean soma area following 
A 
Figure 3.6. Lentiviral transduction of neurons in rRTN. (A) The rRTN showing lentiviral 
transduced neurons containing CaMKIIα (red), GAD67 (green) and DAPI (blue). Image 
obtained with a 10x objective. Scale bar = 100 µm. (B) Image of rRTN taken with a 40x 
objective lens, indicating glutamatergic neurons (red) do not colocalize with GABAergic 
neurons (green). DAPI staining (blue) indicates cell nuclei. Scale bar = 100 µm. (C) 
Schematic diagram representing the approximate location (red) of lentiviral transduced 
neurons in the thalamus. Rt = rRTN, ic = internal capsule, AVVL = anteroventral thalamic 





6-OHDA lesions compared to neurons of sham lesioned animals (Two-tailed, Mann-Whitney 
test; p < 0.0001). 
 Following 6-OHDA lesions, the number of neurons positively stained for GAD67 in 
the rRTN had increased by approximately 20%, while the mean soma area of these 
GABAergic neurons had decreased by 20%, suggesting that 6-OHDA lesions leads to an 
increased number of smaller GABAergic neurons in the rRTN.  
 The relationship between a strong behavioural deficit, indicative of a greater 
dopaminergic lesion, and the change of GABAergic transmission in the rRTN, was assessed. 
However, no correlation between the step testing scores and the number of GABAergic 
neurons in the rRTN was observed (Pearson’s r correlation; r = -0.29, n = 5, p = 0.63). 
Therefore, the increase in rRTN GABAergic neurons appeared to be independent of 
dopamine neuron loss.  
 To investigate whether 6-OHDA lesions had a similar effect on the novel 
glutamatergic population of neurons in the rRTN, neurons positive for the marker CaMKIIα 
were counted in sham and 6-OHDA lesioned animals (Figure 3.7 D). Interestingly, despite an 
increased number of GABAergic neurons, no differences were observed in the mean number 
of glutamatergic neurons in sham and 6-OHDA lesioned rats suggesting that these neurons 
were relatively unaffected by 6-OHDA lesions (p = 0.18).  Consequently, I did not assess the 
size of glutamatergic neurons nor did I test if the glutamatergic neuron count correlated with 









     
    
Figure 3.7. Comparison of stereology corrected neuron counts and soma area 
measurements in sham and 6-OHDA lesioned animals. (A) The mean volume (µm3) of the 
rRTN was measured with the Cavalieri estimator in sham (n = 4) and 6-OHDA lesioned rats 
(n = 5). (B) The mean total number of GABAergic neurons counted in the rRTN in sham and 
6-OHDA lesioned rats. Stereology corrected numbers. * = p ≤ 0.05. (C) The mean measured 
soma area (µm2) of GABAergic neurons in the rRTN in sham and 6-OHDA lesioned animals. 























































































































 The RTN is thought of as an exclusively GABAergic nucleus that provides inhibitory 
input to the rest of the thalamus and has a large impact on the messages that are travelling to 
and from the cortex. The rRTN is involved with the processing of motor information with 
numerous afferent inputs from motor related areas of the basal ganglia, SNc, motor thalamic 
nuclei and motor cortex, and has efferent projections to the motor thalamus. However there is 
a distinct scarcity of information regarding the role that the pathology of the rRTN has in 
movement related disorders such as PD.  
 The present study investigated the phenotype of neurons in the rRTN hypothesizing 
that the majority of neurons in the rRTN would be GABAergic and a small novel population 
that has a glutamatergic phenotype exists based on a previous electrophysiology study in our 
lab. Following characterization of these neurons, it was hypothesized that chronic 6-OHDA 
induced dopamine depletion in the SNc and VTA would not have an effect on the number or 
morphology of neurons in the rRTN. 
 To characterize the phenotype of neurons in the rRTN, GAD67 and CaMKIIα 
antibodies were used as markers for GABAergic and glutamatergic neurons, respectively, and 
were revealed with fluorescent and chromogen immunohistochemistry. Both types of neurons 
were found in the rRTN revealing a novel glutamatergic population of neurons. Furthermore, 
a lentiviral vector was injected into the rRTN driven by a CaMKIIα promoter to selectively 
label these glutamatergic neurons. Lentiviral transduction occurred for 6 weeks, after which, 
dual-labelling immunohistochemistry for GAD67 and the mCherry fluorophore of transduced 
neurons confirmed that the glutamatergic population existed within the rRTN and that this 
population was distinct from GABAergic rRTN neurons. 
 To investigate the effect of dopamine loss on the morphology and number of neurons 
in the rRTN, the dopaminergic neurons in the midbrain were lesioned with the neurotoxin, 
6-OHDA. Dopaminergic lesions of the SNc and VTA were confirmed behaviourally and with 
qualitative immunohistochemistry. Degeneration of the dopaminergic fibres surprisingly led 
to an increase in the number of neurons positive for GAD67 staining. Furthermore, we 
quantified the soma area of GABAergic rRTN neurons and found that it was 20% smaller in 
6-OHDA lesioned rats than in sham lesioned animals. Dopaminergic lesions had no effect on 
the volume of the rRTN or the small population of glutamatergic neurons in the rRTN.  
 The existence of a novel population of neurons raises numerous questions about the 
current understanding of the rRTN.  However, despite being an aim for this study, technical 
difficulties meant that the targets of these neurons remain unknown. Furthermore, 6-OHDA 
induced changes in the rRTN may add important information to the ever growing evidence 
regarding the pathophysiology of PD. The rRTN may stand as a promising new therapeutic 
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target for intervention strategies such as electrical or optogenetic deep brain stimulation. 
Targeting this novel population of neurons might be a key factor in easing the symptoms of 
PD and improving the quality of life of those who are exposed to the disease. 
4.1 Distinct novel population of neurons in the rostral reticular thalamic nucleus 
 The majority of neurons in the rRTN are GABAergic (Houser et al., 1980). Indeed 
staining for the GABAergic marker, GAD67 was seen throughout the nucleus in the classical 
reticulated arrangement caused by the thalamocortical and corticothalamic fibres that 
penetrate through the RTN. These GABAergic neurons were either large or medium-sized 
with a fusiform shape to the soma, which are similar to the reported shapes for other RTN 
sectors (Yen et al., 1985; Spreafico et al., 1988).  
 Early studies into the RTN stated that the majority of cells in the RTN were 
GABAergic but suggested that a minor population was not (Houser et al., 1980). Spreafico et 
al., (1991) identified 3 morphological types of cells in the RTN - small and large fusiform 
types, and small round neurons. The present study positively identified the first two 
morphological types that were stained for GAD67 and the third type as immunoreactive to 
CaMKIIα. This third shape of neuron has also been reported previously in an electron 
microscopic study on a model of absence epilepsy, however the phenotype of these cells was 
not recorded (Nagaeva et al., 2006). Similarly, Cavdar et al., (2013) have recently reported a 
small population of neurons in the RTN that did not show staining for GABAergic markers. 
These neurons were smaller than GABA-positive cells, however the phenotype of 
GABA-negative cells was not investigated further (Çavdar et al., 2013).  
 Here we report that a novel population of neurons exists in the rRTN that are positive 
for CaMKIIα indicating they are glutamatergic (Colbran, 1992; Hanson and Schulman, 1992). 
This novel population presumably accounts for some the previous records of a heterogeneous 
population of cells in the RTN (Houser et al., 1980; Gonzalo-Ruiz et al., 1996; Nagaeva et al., 
2006; Çavdar et al., 2013). Previous work in our laboratory recording activity of rRTN 
neurons found a population with broad extracellular action potentials indicative of 
glutamatergic neurons (Little, 2014). CaMKIIα-positive neurons were sparse, accounting for 
less than 5% of neurons counted in the rRTN. Although this constitutes a small proportion of 
neurons in the rRTN, it does not mean this population is insignificant. For example, striatal 
cholinergic interneurons make up 1 – 3% of the total population of neurons in the striatum 
(Houser et al., 1985; Goldberg and Reynolds, 2011), however, these cholinergic interneurons 
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have a large role in modulating the firing rate of the MSN output neurons causing diverse and 
complex responses in MSNs mediated through post- and pre-synaptic mACh and nACh 
receptors (Gonzales and Smith, 2015).  Cholinergic interneurons regulate attentional and 
reward learning behaviours of animals (Goldberg and Reynolds, 2011; Gonzales and Smith, 
2015), as well as, synaptic plasticity within the striatum (Gonzales and Smith, 2015). This 
raises the possibility that the sparse population of glutamatergic neurons in the present 
experiment may have an important functional role in the rRTN or wider thalamus, despite 
being a small proportion of the total population of neurons within the rRTN. 
 CaMKIIα-positive neurons had round perikarya and generally appeared smaller than 
GAD67-positive neurons within the rRTN. Glutamatergic neurons are known to exhibit this 
shape, which is sometimes referred to as ovoid, and is present in other thalamic nuclei 
containing glutamatergic neurons such as the VA/VL (Sawyer et al., 1989), and the Pf-CM 
complex (Tseng and Royce, 1986; Deschênes et al., 1996).  
 The lentiviral vector that was injected into the rRTN allowed selective labelling of 
neurons driven by a promoter for the CaMKIIα protein as well as immunohistochemical 
detection of the mCherry fluorophore that was part of the genetic makeup of the viral vector. 
Selective labelling of neurons with the CaMKIIα proteins indubitably confirmed the presence 
of a distinct population of glutamatergic neurons within the rRTN. Injection of lentiviral 
vectors may lead to a limited immune or inflammatory response that may alter the 
morphology of neurons (Annoni et al., 2007; Parr-Brownlie et al., 2015), but transduced 
neurons in this study exhibited a similar shape to those immunostained with the CaMKIIα 
antibody suggesting that limited or no immune or inflammatory response following 
injections. However, the transduced neurons seemed to follow the path of injection, perhaps a 
sign that some damage to the tissue occurred following the mechanical injection of the virus 
or the path of least resistance of diffusion.  
 At present it is not clear what function these glutamatergic neurons in the rRTN have. 
Nevertheless, glutamatergic neurons with a fusiform shape in the VA/VL were identified as 
thalamocortical projection neurons (presumably with collaterals to the rRTN). However these 
neurons also had “bushy” appearance with a number of dendrites extending from the soma 
that is commonly described in most thalamic nuclei (Sawyer et al., 1989), which the rRTN 
glutamatergic neurons did not show. Therefore, rRTN glutamatergic neurons may exhibit 
some unique characteristics compared to glutamatergic neurons in other thalamic nuclei.  
 It has previously been thought that interneurons of the rRTN play an important role in 
the communication between the different sectors of the rRTN (Crick, 1984). However, 
questions regarding the presence of a GABAergic population of interneurons in the RTN have 
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been raised, with new evidence suggesting that GABAergic interneurons are not present in the 
rRTN in adult rats but are found in rats under 2 weeks of age (Hou et al., 2016). While further 
evidence would be required, this novel glutamatergic population of neurons could indeed act 
in an interneuron capacity, linking the different sectors of the RTN together to ensure proper 
communication.  
 Unfortunately the attempt to trace these neurons with this viral vector was 
unsuccessful due to the virus diffusing into other structures and subsequently transducing 
neurons in that structure. Although targets could not be specifically identified, a number of 
structures could be speculated to be the targets of these glutamatergic neurons based on the 
action it would have in the cortico-BG-RTN-thalamocortical circuits. 
 With regards to movement, the activity of the rRTN is thought to ensure temporally 
precise inhibition of the thalamus allowing clear passage of the appropriate motor signals to 
the motor cortex (Marlinski et al., 2012). GABAergic neurons of the rRTN are thought to 
achieve this with changes in their bursting activity pattern. Recent evidence obtained in our 
laboratory found that putative glutamatergic neurons in the rRTN also fire in a bursty pattern 
(Little, 2014). It could therefore be assumed that this temporality is achieved through activity 
in both glutamatergic and GABAergic neuron populations. The most logical synaptic target 
for the glutamatergic neurons in the rRTN would be to the motor thalamus, as the only 
GABAergic output from the RTN that has been defined to date is to other thalamic nuclei 
(Pinault, 2004). Excitatory input from the rRTN to the motor thalamus could act in two ways. 
Firstly, to enhance the signal that is going up to the cortex through excitatory activation of 
thalamic relay cells, meanwhile other non-important signals are inhibited by the RTN. This 
again achieves a precise temporality to the appropriate motor signals for the intended target. 
Secondly, this glutamatergic population may be acting as a functional reserve, so that if a high 
priority event occurs that requires immediate attention or alteration of the projected 
movement these neurons could reverse the effects of the inhibitory GABAergic input to the 
motor thalamic neurons.  
 As suggested earlier, RTN neurons may act as interneurons that allow for 
communication between sectors of the RTN. Glutamate can cause excitation or inhibition of 
RTN neurons depending on the receptor that it activates. Glutamatergic activation of RTN 
neurons causes fast excitatory post synaptic potentials mediated through AMPA and NMDA 
receptors (Lacey et al., 2012; Deleuze and Huguenard, 2016). These responses are sufficient 
to activate T-type Ca2+ channels that can lead to a change from tonic to bursty activity in RTN 
neurons if they were previously hyperpolarised (Deleuze and Huguenard, 2016).  Therefore, 
this glutamatergic population acting as interneurons would promote the burstiness of their 
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interconnected neurons, which would act to enhance the inhibitory output of particular 
neurons, in a particular sector and ensure that the each sector and their functionally connected 
thalamic relay neurons are responding to external stimuli appropriately (Pinault, 2004). 
Additionally, glutamatergic action through group I and group II mGluRs leads to LTP and 
LTD, respectively, induced synaptic plasticity (Wang et al., 2015; Neyer et al., 2016). If this 
glutamatergic population of neurons were to act as interneurons, this mGluR mediated 
mechanism of synaptic plasticity provides a form of communication where the strengthening 
and weakening of particular synapses by LTP and LTD, respectively, may be driven by local 
modulation of these interneurons. 
 The CM nucleus is part of the thalamo-striatal-basal ganglia loop and is important in 
the changing of attention and reward-related motor tasks (Henderson et al., 2005; 
Minamimoto et al., 2005; Smith et al., 2014; Galvan et al., 2015). CM thalamic efferents to 
the striatum synapse onto GABAergic MSNs of the striatum, and increase the firing rate of 
MSN output neurons (Smith et al., 2014). Single pulses from CM neurons do not elicit 
responses in MSNs, which require burst firing to be activated (Nanda et al., 2009). It is 
believed that this system helps to alter activity in the basal ganglia in response to attention-
related stimuli (Smith et al., 2014). This raises the striatum as another potential target for this 
glutamatergic population of neurons in the rRTN. The RTN is commonly described to act as a 
gateway for information coming from the thalamus and is able to focus on stimuli that require 
our immediate attention while simultaneously inhibiting irrelevant information (Pratt and 
Morris, 2015). The RTN is known to send GABAergic projections to the CM (Steriade et al., 
1984). Speculatively, if the glutamatergic population in the rRTN were to project to the 
striatum and act to ‘highlight’ stimuli that require attention, a direct loop would be formed 
that allows simultaneous inhibition in the CM, therefore reducing the CM-mediated excitation 
of the striatum, as well as excitation of the striatum by the rRTN itself. 
4.2 Parkinsonism affects the rostral reticular thalamic nucleus 
 The effects of 6-OHDA induced Parkinsonism on the number and morphology of 
GAD67 and CaMKIIα stained neurons in the rRTN was investigated and compared against a 
sham lesioned control group. Following lesion of the SNc and VTA via 6-OHDA injections 
into the MFB, the number of cells positive for GAD67 staining increased compared to sham 
injections into the same area. This increase in rRTN GABAergic neuronal number did not 
correlate to the degree of dopaminergic lesion that was indicated by the behavioural deficit 
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displayed by lesioned animals. Previous reports have shown that behavioural performance can 
indicate the extent of dopaminergic neuron loss in the SNc and VTA (Tseng et al., 2005). 
This suggests that the increase in GAD67-positive neurons may occur early in the progression 
of dopaminergic lesions and does not require a substantial lesion to midbrain dopamine 
neurons. The immunohistochemistry completed in this thesis was targeted for GABAergic or 
glutamatergic neurons in the rRTN. While counting, it was noted that this staining seemed to 
account for most of the neurons in the structure, however, this would have been made clearer 
with a general neuronal stain such as Nissl staining. It is presented in this thesis that the rRTN 
contains approximately 1200 cells. To the best of my knowledge, only one other group has 
reported a total neuronal count in the RTN (Sabers et al., 1996). Sabers et al., (1996) counted 
up to 30,000 total cells in the entire RTN structure, which covers up to 3 mm in the 
rostro-caudal axis. In contrast, the rRTN that was counted in this thesis was only 0.4 mm in 
the same axis, which would account for the difference in neuronal number. 
 Although research into the effects of a dopaminergic lesion on the rRTN is scarce, it 
has previously been found that the mRNA encoding the enzyme GAD67, which is involved in 
the synthesis of GABA, is increased following 6-OHDA induced lesions in rats (Delfs et al., 
1996). This increase in GAD67 mRNA was independent of the dose of 6-OHDA given, 
suggesting that the changes to expression of GAD67 mRNA are independent to the size of 
dopaminergic lesion (Delfs et al., 1996). The CM/Pf complex is similarly affected by 
dopaminergic depletion of the midbrain. In 6-OHDA and MPTP lesioned animals, and human 
patients with PD, loss of neurons in this intralaminar thalamic complex is not associated with 
the degree of dopaminergic lesion (Henderson et al., 2000a, 2000b; Kusnoor et al., 2012; 
Villalba et al., 2014). One interpretation is that the rRTN may have a role in the non-motor 
symptoms of PD, which occur earlier than the motor symptoms that become apparent when 
up to 70% of dopaminergic neurons are lesioned (Fearnley and Lees, 1991). For example, it is 
possible that the disruption of normal activity in the rRTN as seen presently and in previous 
work in our lab (Little, 2014), of the RTN spreads to the other sectors of the RTN through 
electrical gap synapses (Blethyn et al., 2008), or the proposed glutamatergic RTN 
interneurons (see above). Through this route, the pathological changes to the RTN could 
affect other sectors of the RTN, such as the limbic sector, which may contribute to deficits in 
motivation as well as the depressive symptoms seen in some patients with PD (Remy et al., 
2005; Park and Stacy, 2009). Furthermore, global synchronization of bursty activity in the 
RTN that occurs during the development of sleep spindles (Fuentealba and Steriade, 2005), 
may be disrupted by the spread of pathology to all sectors of the RTN. The role that the RTN 
may have in the sleep disturbances experienced with PD is further discussed below. 
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 The increase in GABAergic neurons did not coincide with an increase in the volume 
of the rRTN. However, the soma of identified fusiform GABAergic neurons were smaller 
compared with the sham lesioned group. Typically, when somal area is measured a marker for 
the nucleus is used (Derecki et al., 2012; Amorin and Calisi, 2015). GAD67 immunoreactivity 
clearly labelled the soma and around the nucleus of GABAergic neurons in this study, despite 
not using a nucleus marker. Furthermore, sham lesioned animals had neuronal soma area 
measurements similar to what has previously been reported in the rRTN of adult rats of 
around 150 – 200 µm2 (Ohara and Lieberman, 1985), indicating that use of the nuclear marker 
is not essential for this analysis.  
 Together these data suggest that although dopamine loss is required to change the 
number and the morphology of GAD67 expressing GABAergic neurons and it does not 
require a large lesion to induce these effects. The number of neurons positive for CaMKIIα 
was not affected by 6-OHDA lesions, nor was the morphological appearance.  
 The findings of Delfs et al. (1996) raises the issue of whether or not an actual increase 
in neuronal number was found or whether the increase of GAD67 mRNA confounded the 
neuronal cell counts. The levels of GAD67 mRNA are directly correlated with the levels of 
the GAD67 enzyme (Gierdalski et al., 2001; Lau and Murthy, 2012), which was targeted with 
immunohistochemistry in the present experiment. However, Delfs et al. (1996) employed in 
situ hybridization methods to measure mRNA expression of GAD67, and the number of 
neurons in the rRTN was not reported. All care was taken to ensure that stereological cell 
counts of the rRTN were unbiased and potential confounding elements were reduced with the 
use of the Optical Fractionator method alongside strict use of unbiased counting rules. 
Although it is possible that due to the ambiguity between different portions of the RTN, small 
parts of the caudal neighbours of rRTN could have been included in the neuron counts, adding 
to the total. Kincaid and colleagues report that 6-OHDA caused increased expression of 
mRNA of GAD67 per neuron in the GPe as well as an increased percentage of neurons in the 
GPe that express immunoreactivity to GAD staining (Kincaid et al., 1992). Similarly, mRNA 
expression of GAD67 and the number of neurons expressing GAD67 were increased in the 
barrel cortex of mice following sensory learning (Gierdalski et al., 2001) indicating the 
GABAergic neuron numbers are altered under physiological and pathological conditions.  
 In the RTN, however, the majority neurons are already immunoreactive to GAD67 
staining and if a small percentage of GAD67 negative neurons started to express the enzyme, 
the difference is unlikely to account for the increases seen presently. Interestingly, during 
normal ageing of a rat, the RTN undergoes changes in its neuronal density. From young 
adulthood at 3 months of age to the later age of 24 months the number of neurons per mm2 of 
 
 79 
RTN tissue progressively declines. As a rat enters old age at 24 months to 30 months, the 
number of neurons per mm2 in the RTN increases (Ramos et al., 1995; Çavdar et al., 2013). 
The rats in the present study were around 4 months old at the end of their experimental life 
and therefore into young adulthood and should be in a period of decline in the number of 
neurons per mm2 in the RTN. One interpretation is that 6-OHDA lesions of dopaminergic 
neurons in the SNc cause premature ageing in rats, thereby disrupting the normal ageing 
process and accounting for the increased number of GABAergic neurons in the rRTN 
presented in this thesis. Indeed, ageing is a major risk factor for the development of PD with 
an increased prevalence of PD in human patients over 60 years of age (Aarsland et al., 2001). 
In addition to this idea, during normal ageing, neurons of the basal forebrain in humans and 
the cortex of rats go through a period where their size increases, which is followed by a 
subsequent 10% reduction in size in older age (Diamond et al., 1977; de Lacalle et al., 1991). 
Therefore, this premature ageing may account for the decrease in the size of GABAergic 
neurons seen presently. We minimised this factor by ensuring that sham lesioned control 
animals were of the same age as 6-OHDA lesioned animals and all tissue was processed 
together under the same conditions. There is currently a lack of research on the effects of 6-
OHDA lesions on ageing in rats. However, in a highly used model of ageing in the worm, C. 
Elegans, genetic techniques were used to increase the lifespan of PD-mutant worms and it 
was found that PD-like symptoms were alleviated and α-synuclein aggregates were prevented 
(Cooper et al., 2015). This suggests that a dopaminergic deficit may alter neurons of the brain 
and make them more susceptible to the processes of ageing. In the rRTN, this may manifest as 
an increase in the number of GABAergic neurons and a decrease in the size of these neurons.  
 It becomes interesting to speculate on which inputs to the rRTN are responsible for the 
changes in the levels of GAD67, and indeed it is likely a combination of all inputs – most of 
which are also altered following 6-OHDA intoxication. The SNc sends dopaminergic input to 
the rRTN (Florán et al., 2004; Gasca-Martinez et al., 2010), which would likely be lost with 
dopaminergic lesions leading to direct changes in the rRTN. Dopaminergic input from the 
SNc acts to reduce GABA inhibition of rRTN neurons (Gasca-Martinez et al., 2010), so loss 
of dopamine will increase the inhibition of rRTN neurons by GABAergic inputs from the 
overactive SNr, among others. This may lead to hyperpolarization of the rRTN membrane 
potential resulting in an increased bursty pattern of activity, which is accompanied by an 
increase in GABA synthesis enzymes i.e. GAD67, GABA synthesis and GABA transmitter 
release (Delfs et al., 1995; Bosch-Bouju et al., 2013). Pharmacological antagonism of the 
dopaminergic D4 receptors, which are present in the rRTN (Florán et al., 2004), leads to a 
reduction of motor activity (Zhang et al., 2002). In the present study D4 receptors would not 
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be activated due to a lack of dopamine rather than by antagonism, however, a similar 
reduction in motor activity was seen, suggesting that the changes to the rRTN that contribute 
to movement deficits are a consequence of reduced dopaminergic activity from the SNc input 
to the rRTN, at least in some capacity. However, to confirm this assumption, the rRTN would 
need to be isolated in the pathology of the disease. 
 As previously described D4 receptors in the rRTN are located on presynaptic 
terminals of GABAergic inputs from the GPe, GPi and SNr (Gasca-Martinez et al., 2010) 
suggesting that dopamine loss may not directly affect rRTN neurons but instead modulates 
GABAergic signalling in the nucleus. Furthermore, increases in GAD67 mRNA expression 
following 6-OHDA lesions have been reported for the striatum, GPi, GPe and SNr (Kincaid et 
al., 1992; Soghomonian and Chesselet, 1992; Soghomonian et al., 1992; Delfs et al., 1995; 
Rodríguez Díaz et al., 2003). Of these structures, the primary dopaminergic projections are to 
the striatum, although the SNc also has some projections to the GPe (Freeman et al., 2001; 
Anaya-Martinez et al., 2006). However, none of these reports have quantified neuronal 
number. It seems that dopamine loss in the SNc leads to an increase of GAD67 expression, 
which leads to increased GABA neurotransmission in most nuclei of the basal ganglia and the 
motor thalamus (Galvan and Wichmann, 2008). For example in the GPe, where an increase in 
the mRNA of GAD67 has lead to an increase in the likelihood of burst firing (Pan and 
Walters, 1988; Filion et al., 1991; Delfs et al., 1995). 
 The size of GABAergic neurons was reduced in the rRTN in this thesis. A reduction in 
the size of neurons occurs with old age as previously mentioned (Diamond et al., 1977; de 
Lacalle et al., 1991), and in pathological conditions, such as, Rett syndrome which is an 
autism spectrum disorder, where in a genetically modified mouse model the somal area of 
hippocampal cells are decreased compared with normal wild-type mice (Derecki et al., 2012). 
It is not presently known what causes this reduction, however, in PD, the increased busty 
activity in the GPe, as well as the overactive SNr would lead to an increase in the release of 
GABA from GPe and SNr terminals in the rRTN. The GPe and SNr inputs are mainly to 
primary dendrites and somata of rRTN neurons (Paré et al., 1990; Asanuma, 1994), Therefore 
it could be speculated that in PD the changes to these nuclei leads to a compensatory decrease 
in rRTN neuronal soma size in an attempt to normalize the inhibition from GPe and SNr 
neurons by decreasing the available area for GABA to have its actions. Although this yet to 
be substantiated, the opposite of this idea is true in the hippocampus, where decreases in input 
activity to hippocampal cells in culture resulted in a compensatory increase in the size of 
neurons to increases synaptic reliability and strength (Murthy et al., 2001).    
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 Recent evidence recorded in this laboratory found an increase in the likelihood of any 
individual rRTN neuron to exhibit LTS bursting activity following 6-OHDA induced 
dopamine lesions (Little, 2014). Therefore, increases in the number of GABAergic neurons in 
the RTN, as found in this thesis, combined with increases in LTS bursting activity within each 
neuron would cause a large increase in the inhibitory signal that modulates activity of the 
thalamic relay neurons. The consequent disruption of the temporality that is required for 
normal movements (Marlinski and Beloozerova, 2014), may underlie some of the motor 
symptoms seen in patients with PD. Additionally, a decrease in the area of the somata reduces 
the area available to receive messages of inputs that synapse onto the soma of RTN neurons 
such as the thalamocortical and corticothalamic collateral terminals and inputs from the basal 
ganglia (Paré et al., 1990; Asanuma, 1994; Liu and Jones, 1999). The “noisy signal” pattern 
of activity is a mechanism that has been suggested to underlie dysfunction in basal ganglia 
networks, where pathological activity in the nuclei of the basal ganglia disrupts the normal 
pattern of activity required for movements (Brown and Eusebio, 2008), therefore, the changes 
to the rRTN found in our lab suggests that the rRTN may add to this noise and contribute to 
the disruption of movement in PD.  
 Despite the limited range of evidence regarding changes to the RTN in Parkinsonian 
conditions, other neurological conditions may help understand how changes to the RTN may 
affect the wider networks of the brain. The RTN is implicated in the generation of the 
oscillatory activity through the thalamocortical-thalamic loop, that is thought to be important 
in the normal functioning of the brain but can become pathological (Pinault, 2004). Spike and 
wave discharge (SWD) patterns are a characteristic feature of absence epilepsy and develop 
when oscillatory activity in this network is abnormally expressed (Steriade, 2005). 
GABAergic neurotransmission from the RTN is thought to play an important role in the 
generation and maintenance of this SWD pattern (Steriade, 2005). In animal models of 
absence epilepsy, the mRNA expression of GAD67 has been reported to be increased (Lin et 
al., 1999), a change which is similarly seen in PD. Furthermore, it was suggested that this 
increase in GAD67 expression and subsequent increase of GABAergic synaptic transmission 
by RTN neurons projecting to thalamic relay neurons reduced the ability of the relay neurons 
to participate in synchronized burst firing (Lin et al., 1999). Normal synchronized activity of 
thalamic relay neurons in the motor thalamus is essential for the development of movement 
and is transiently allowing the temporally precise flow of motor message to the cortex 
(Hammond et al., 2007). In PD, the increased GABAergic synaptic transmission from the 
rRTN as well as from nuclei of the basal ganglia would override this transient 
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synchronization, impeding the development of a motor pattern and could account for some of 
the bradykinetic and akinetic features of the disease. 
 The current study did not find any differences in the number of neurons positively 
stained for CaMKIIα, however, it must be noted that the ratio of GABAergic and 
glutamatergic neurons counted in the rRTN was fairly constant across sham and 6-OHDA 
lesion groups. Previously this lab has found that the activity of presumed glutamatergic 
neurons decreased and the incidence of LTS bursts was increased in the PD model (Little, 
2014). These changes to the firing pattern of glutamatergic neurons are similar to those 
described in the STN (Delaville et al., 2015). Although an increase in glutamatergic neurons 
was not teased out with statistical testing, the constant ratio of glutamatergic neurons to 
GABAergic neurons suggests that both types of neurons within the rRTN may have increased. 
It is hard to know what this would do to the wider system, without knowing where the 
glutamatergic outputs are going, however, it could be stipulated that this increase in neuronal 
number as well as a change to the firing pattern would upset the messages being conveyed 
through the rRTN. However, to fully understand the effects of PD on this small population of 
neurons in the RTN, additional investigation is required.  
4.3 Exploring the rostral reticular thalamic nucleus as a novel targets in the treatment of 
Parkinson’s disease 
 Research into the changes in the rRTN in PD has been limited. However, it appears 
from this study that more GABAergic neurons are present in the rRTN, as well as increased 
expression of GAD67 (Delfs et al., 1996). The consequence of this increased GABAergic 
tone may increase the inhibition of thalamic relay neurons and change the temporal pattern of 
activity that is required for a number of processes throughout the brain. During skilled 
movements in non-lesioned rats, the RTN fires in bursts of action potentials that provide 
thalamocortical neurons with inhibition in a pattern that is precisely timed with the movement 
(Marlinski and Beloozerova, 2014). Additionally, it was found that neurons of the rat motor 
thalamus fire in a precise pattern of activity that is specifically timed to executing a skilled 
reaching movement, where there are periods of inhibition before and after the movement and 
a peak of excitation as the movement is occurring (Bosch-Bouju et al., 2014). This 
modulation is abolished in 6-OHDA lesions (Bosch-Bouju et al., 2014), which could 
theoretically be due to altering the precise temporal nature of the inhibitory input from the 
RTN. Therefore the rRTN offers a potential novel target for therapies that alleviate the 
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symptoms of PD. Furthermore, this nucleus may offer a target for the treatment of not only 
the motor symptoms, but also the non-motor features of the disease due to the involvement of 
the RTN in processes such as attention and sleep. 
 The increases in the numbers of GAD67 positive neurons, seen presently, and the 
expression of GAD67 mRNA (Delfs et al., 1996), and subsequent changes in GABAergic 
synaptic transmission occurs not only in the rRTN, but in the striatum and SNr, where this 
change has received a lot more attention. It is thought that by modifying the GAD gene in PD 
it is possible to return GABA transmission back to normal and indeed a number of studies in a 
rat model of PD have reported that behavioural symptoms are reduced following GAD gene 
therapy (Horvath et al., 2011; Wettergren et al., 2014). These studies utilize interference RNA 
(RNAi), which are incorporated into the GAD67 mRNA and disrupt production the enzyme 
(Wettergren et al., 2014). Injecting lentiviral vectors, expressing RNAi to knockdown GAD67 
isoforms, into the striatum or SNr restored normal GAD67 levels and alleviated the motor 
symptoms of PD in rats (Horvath et al., 2011; Wettergren et al., 2014). The present results 
indicate that GAD67-expressing neurons are increased in the rRTN, therefore, GAD gene 
therapy targeted to the rRTN may improve the symptoms of PD similar to the effects seen in 
the striatum and SNr. By reducing the levels of GAD67 in the rRTN, through RNAi induced 
knockdown, GABAergic inhibition of the thalamic relay neurons by the rRTN will be reduced 
and the appropriate motor signals that are impaired in PD might be restored. GAD gene 
therapy is a promising upcoming treatment with trials of viral-vector induced expression of 
GAD67 in human patients already underway (Kaplitt et al., 2007), although targeted in the 
STN. However, further rRTN studies are required before conducting trials that modify 
GABAergic rRTN transmission. 
 Non-motor symptoms occur in up to 90% of patients that live with PD, and most 
non-motor symptoms are not responsive to the gold standard treatments offered such as 
L-DOPA. Additionally, non-motor symptoms can occur earlier in the progression of the 
disease than the hallmark motor symptoms and often go undiagnosed (McDowell and 
Chesselet, 2012). It is critical that the non-motor symptoms of PD are better understood to 
ensure early detection of PD and to improve the quality of life of those already living with the 
disease.  
 Sleep disturbances are a common non-motor symptom of PD and affect around 80% 
of patients (Factor et al., 1990; McDowell and Chesselet, 2012).  As mentioned in Section 1.1, 
the RTN has a role in the generation of sleep spindles – a hallmark oscillatory pattern that 
occurs during light non-rapid eye movement sleep (Steriade et al., 1993; McDowell and 
Chesselet, 2012). Therefore, the RTN represents an interesting nucleus to target treatment to 
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alleviate sleep disturbances in Parkinsonian patients. Burstiness of the rRTN is a key activity 
pattern that synchronizes the rRTN and thalamocortical relay neurons leading to the slow 
oscillatory rhythm important for non-rapid eye movement sleep (Fuentealba and Steriade, 
2005). As previously mentioned, the pathology of absence epilepsy is characterized by SWDs 
that oscillate at an increased frequency compared with sleep oscillations (Fuentealba and 
Steriade, 2005). During SWDs, the neurons of the RTN synchronise in firing with bursty 
pattern more regularly, and this burst is much longer than before seizures (Steriade and 
Contreras, 1995). PD increases the number of GABAergic neurons in the rRTN as reported 
presently, which likely leads to increased bursty activity of the neurons in this nucleus (Little, 
2014). Therefore, disturbing the sleep oscillations with increases in the number and the 
likelihood of burst firing in rRTN neurons (Little, 2014), which is induced by dopamine 
depletion, may underlie the sleep disturbances and poor sleep patterns of PD patients. In 
Parkinsonian patients, low-frequency stimulation of the rRTN did not alter sleeping patterns 
but did alleviate resting tremor, however, these patients did not have a previous history of 
sleep disturbances (Arnulf et al., 2000). At low-chronic doses of 6-OHDA, the so called 
‘clock’ gene PER2 that regulates the circadian rhythm of rats is altered in the striatum 
(Gravotta et al., 2011). This disruption of normal rhythmic function may provide a model that 
could investigate sleep disturbances in PD (Gravotta et al., 2011). However, to the knowledge 
of this researcher there have not been investigations looking at RTN activity with regards to 
sleep disturbances in animals with 6-OHDA lesions.  
 Advancing our understanding of the RTN in the pathophysiology of motor and 
non-motor symptoms of PD is vitally important to improve treatments for patients, as well as 
early identification of Parkinsonian symptoms. Changes to the normal anatomy and 
physiology of neurons that occur in PD are complex and affect a number of areas of the brain. 
The RTN receives considerable inputs from many of these areas, and projects to thalamic 
relay neurons, but it has often been ignored in the treatment of PD. Restoring normal activity 
in the thalamus could normalize activity throughout the brain (Seeger-Armbruster et al., 
2015), and the RTN represents an important target for future treatment endeavours. 
4.4 Technical considerations 
4.4.1 Definition of the rRTN boundary  
 The RTN is functionally segregated into many sectors of different modalities. 
Represented at the rostral end of the nucleus are the limbic, and motor sectors (Jones, 1975; 
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Pinault, 2004). The sector pertaining to visceral information lies just caudal to the motor 
related rRTN and the limbic sector is the rostral neighbour of the motor sector (Jones, 1975; 
Cicirata et al., 1990; Stehberg et al., 2001). Each sector is reasonably singular in its functional 
afferent and efferent pathways with little or no overlap (Pinault, 2004), however there is no 
strict anatomical delineation that separates individual sectors. Therefore, in the present study, 
the definition of the rRTN was designed to be consistent with previous literature that had 
specifically looked at the motor sector of the RTN (Cicirata et al., 1990; Delfs et al., 1996; 
Picazo et al., 2009; Villalobos et al., 2016). Despite this, it is possible that portions of the 
limbic and visceral sectors may have been included in the reported cell counts. The motor 
portion of the RTN receives inputs from motor thalamus, the GPe and the SNr, which are 
found only in the rostral portion of the RTN (Delfs et al., 1996), the SNr may also project to 
limbic sectors of the RTN (Gandia et al., 1993; Tsumori et al., 2000). The activity of these 
nuclei is altered in 6-OHDA lesions and the rRTN seems to be similarly altered. The 
increased number of neurons in the rRTN seen in the present study may have been 
underreported if the visceral sector of RTN was included in neuronal counts because it has no 
known projections from nuclei mentioned above. Nevertheless, the results of the present study 
are consistent with previous GAD67 mRNA results investigating the affect of a 6-OHDA 
lesion on the rRTN (Delfs et al., 1996).  
4.4.2 Chromogenic versus fluorescent immunostaining  
 Fluorescent immunohistochemistry is a very good method to distinguish two different 
antigens of interest at a high-resolution due to the different wavelengths of light that are 
employed. Each wavelength can be viewed individually, and then merged together to form a 
coherent image. However, the labelling of antibodies with fluorescent antibodies is much less 
sensitive than chromogenic labelling and requires high concentrations of primary antibodies 
and therefore is more expensive. Moreover, high-power fluorescent microscopy that produces 
these high-resolution images is time-consuming and expensive to use on an hourly basis. Due 
to the constraints of an MSc project, fluorescent immunohistochemistry was used sparingly in 
this project and chromogenic labelling was primarily used. Furthermore, access to the 
Stereoinvestigator software was only available in conjunction with chromogen-based light 
microscopy for this study. The detection of antigens that are in close proximity is a lot more 
difficult using the chromogenic system because of the higher sensitivity of the reaction 
products and the limited supply of different colours. DAB is a chromogen that has been used 
for decades and is readily used by this laboratory group. Vector SG was chosen as a second 
label colour due to its compatibility with dual peroxidase stain labelling according to the 
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manufacturer. Vector SG is a less sensitive chromogen than DAB, and staining with this 
chromogen in dual-labelling experiments showed a faint reaction product. This combination 
of reaction products has not been previously reported for dual label neuronal antigens but we 
were able to achieve colour separation. DAB may also cause sheltering of the secondary 
reaction product due to its high sensitivity leading to a high yield of reaction product as well 
as the tendency for the brown DAB reaction product to aggregate producing a more intense 
stain (van der Loos, 2007). The inclusion of antigen-retrieval before application of the second 
primary antibody and vector SG staining and the extremely dilute concentrations of the first 
primary antibody prevented sheltering effects of DAB (Tornehave et al., 2000; van der Loos, 
2007).  
 An alternative to DAB that could have been used in these experiments is 3-amino-9-
ethylcarbazole (AEC), which produces a red reaction product and provides a good contrast 
against the blue vector SG. However, AEC requires mounting with an aqueous mounting 
medium such as glycerol gel and fades over time (van der Loos, 2009), whereas DAB and 
vector SG can be mounted and viewed permanently. 
4.4.3 Lentiviral vector injections  
 To irrefutably confirm the presence of a distinct glutamatergic population of neurons 
in the rRTN, a lentiviral vector was injected into the brain at the stereotaxic coordinates that 
represented the rRTN. Lentiviral vector transduction was driven by a CaMKIIα promoter and 
could easily be identified with the mCherry reporter. The viral vector was also pseudotyped 
with VSVg that ensured transportation of the vector throughout the whole neuron enabling 
anterograde tracing of the neuron. While expression of transduced neurons in the rRTN was 
observed, the injections of the viral vector were not contained within the rRTN and therefore 
any terminals that were subsequently identified could not be accurately reported to be from 
the rRTN. Initially, the coordinates were modified according to the injection path of the 
previous group of rats, beginning with coordinates from previous studies in the lab. Then, a 
smaller volume of virus was injected, which showed some promise. However, transduction of 
the virus was still extended beyond the rRTN boundaries. With each lentiviral injection 
requiring 6 weeks to transduce neurons, on top of 2 weeks between lesion surgeries and 
lentiviral surgeries, the process taken to selectively hit the rRTN was extremely time 
consuming. Due to time constraints inherent to a Masters project, we were unable to complete 
this aim of the project. 
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4.5 Future studies 
 This study has revealed a sparse novel population of neurons in the rRTN that have a 
glutamatergic phenotype. A large number of previous studies have generally believed the 
RTN to be made up of exclusively GABAergic neurons and therefore this glutamatergic 
population may play an important role in the function of the RTN. However, we were not able 
to identify the synaptic targets of the RTN due to the injection path of the viral vector entering 
into other structures. To further understand the function of this novel population it is vital to 
identify the projection patterns of these neurons. Accurately identifying the rRTN before 
injections of the viral vector would be essential and may address the issues of misplaced 
transduction. The changing shape of this structure along its rostro-caudal axis makes the 
accurate injection in any individual rat difficult, to ensure that viral vector transduction is 
limited to the RTN, a small (100 nL) injection volume should be used and a large number of 
rats would be required to eliminate the possibility of transduction of neurons in other 
structures. Stereotaxic electrophysiological mapping before lentiviral vector injections would 
allow precise placement of the viral vector into the rRTN. The RTN has a characteristic 
electrophysiological profile that can be identified while recording activity in live 
anaesthetised animals, and electrophysiological mapping has been used successfully to 
identify the motor and premotor cortex as well as inject lentiviral vectors directly into these 
areas (Galvan et al., 2016). This technique requires a recording microelectrode to be attached 
to the injection tubing for viral delivery. This exact application of the lentiviral vector used in 
the present study would allow post-mortem tracing of the glutamatergic projections and 
possibly reveal a non-thalamic target for the RTN. 
 To extend this idea further, combining electrophysiological mapping with 
optogenetics would enable the in vivo investigation of the glutamatergic neurons in the rRTN. 
Firstly the precise transduction of RTN neurons must occur by using a lentiviral vector, which 
has the capability to add a light-activated cation-selective membrane channel, 
channelrhodopsin-2 (ChR2) specifically into the glutamatergic neuron (Nagel et al., 2003; 
Seeger-Armbruster et al., 2015). Then by stimulating the transduced neurons with light and 
recording in downstream nuclei it is possible to distinguish the functional synaptic targets of 
these neurons (Hira et al., 2013). To avoid the possibility of movement-related artefacts in 
potential target locations, animals could be anaesthetised. Similarly, thalamic relay nuclei 
projections have been specifically mapped to their cortical targets using stimulation of ChR2 
expressing thalamocortical neurons (Cruikshank et al., 2010). 
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 Following the identification of the target nuclei of the glutamatergic population it 
would be interesting to study the effects that optogenetic stimulation has on the behaviour of 
awake animals, which may help clarify the function of these glutamatergic neurons. Lentiviral 
vectors that induce the expression of ChR2 in the motor thalamus have previously been 
shown to change the behaviour of Parkinsonian rats (Seeger-Armbruster et al., 2015). 
Therefore, it would be interesting to see the effects of a similar scenario applied to the rRTN 
in animal models of PD. Although no change to the number of glutamatergic neurons was 
found, previous research conducted by members of this laboratory found that presumed 
glutamatergic neurons exhibited decreased firing rate and increased bursty firing pattern 
following 6-OHDA lesions (Little, 2014). Attempting to restore these neurons back to normal 
activity using optogenetic stimulation may offer a novel treatment paradigm for PD. 
 Presently, the number of GABAergic neurons in the rRTN was increased following 
dopaminergic lesions with 6-OHDA and previous reports indicate an increase in the 
expression of GAD67 mRNA as well as increased bursty activity in the rRTN (Delfs et al., 
1996; Little, 2014). Recently, a channelrhodopsin, which is normally cation-selective and 
causes depolarisation (Nagel et al., 2003), has been engineered that allows the conductance of 
chloride ions that causes light-activated inhibition of neurons (Berndt et al., 2016). 
Alternative light-activated inhibitory channels are available for use, such as halorhodopsin, 
that acts as a chloride pump (Tønnesen et al., 2009) but this chloride-conducting 
channelrhodopsin exerts inhibition more faithfully than halorhodopsins under the control of 
optogenetic stimulation (Berndt et al., 2016). The ability to selectively inhibit rRTN 
GABAergic transmission may have important therapeutic effects in the treatment of PD and 
indeed knockdown of GAD67 in other structures, such as the SNr, has shown to improve 
Parkinsonian symptoms (Horvath et al., 2011; Wettergren et al., 2014). Having the ability to 
provide patterned stimulation, such as theta-burst stimulation (Larson et al., 1986), to these 
neurons may help reduce the consequences of pathological changes in the precisely timed 
GABAergic transmission of the rRTN onto thalamic relay neurons (Marlinski and 
Beloozerova, 2014). Theta-burst patterns of stimulation delivered with transcranial magnetic 
stimulation to the motor cortex has been shown to be effective in the treatment of some 
neurological conditions, such as PD and stroke (Huang et al., 2005), and optogenetic theta-
burst stimulation of excitatory neurons in the motor thalamus reduced behavioural deficits in 
Parkinsonian rats (Seeger-Armbruster et al., 2015). Therefore, optogenetic inhibition 
delivered to the rRTN may act to silence GABAergic transmission and return function back to 
normal. Furthermore, theta-burst stimulation of the inhibitory channelrhodopsin could 
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effectively return the precise temporal pattern of firing exhibited by rRTN neurons under 
normal physiologic conditions (Marlinski and Beloozerova, 2014). 
4.6 Conclusions 
 In conclusion, the current study used immunohistochemistry-staining techniques and 
lentiviral vector technology to specifically characterize the phenotype of neurons in the rRTN. 
Although the majority of neurons in the rRTN were GABAergic, consistent with early reports 
on this nucleus (Houser et al., 1980), a small distinct population of neurons was identified in 
the rRTN and were characterized as glutamatergic cells, a novel finding of this thesis. 
Additionally, stereological methods were utilized to assess the effects of the 6-OHDA lesion 
model of PD on the neuronal population in the rRTN. Dopaminergic depletion caused a 
surprising increase in the number of neurons positively stained for GAD67 in the rRTN, 
which were smaller than GABAergic neurons in sham lesioned animals. No changes to the 
glutamatergic population of neurons in the rRTN were observed. It is further suggested that 
optogenetic inhibition of overactive GABAergic neurons in the rRTN could be a forthcoming 
method in the treatment of PD to improve, not only motor but also non-motor, deficits in 
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